AI assistant
Altek — Interim / Quarterly Report 2024
Nov 14, 2024
52290_rns_2024-11-14_960cbd5b-8ce4-45c2-8ac0-3828cb04b7f2.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS AND
INDEPENDENT AUDITORS’ REVIEW REPORT SIX MONTHS ENDED JUNE 30, 2024 AND 2023 (Stock Code : 3059)
~1~
INDEPENDENT AUDITORS’ REVIEW REPORT TRANSLATED FROM CHINESE
PWCR24000073
To ALTEK CORPORATION
Introduction
We have reviewed the accompanying consolidated balance sheets of Altek Corporation and subsidiaries as at June 30, 2024 and 2023, and the related consolidated statements of comprehensive income for the three-month and six-month periods then ended, as well as the consolidated statements of changes in equity and of cash flows for the six-month periods then ended, and notes to the consolidated financial statements, including a summary of material accounting policies. Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34 “Interim Financial Reporting” that came into effect as endorsed by Financial Supervisory Commission. Our responsibility is to express a conclusion on these consolidated financial statements based on our reviews.
Scope of Review
Except as explained in the following paragraph, we conducted our reviews in accordance with the Standards on Review Engagement 2410, “Review of Financial Information Performed by the Independent Auditor of the Entity” of the Republic of China. A review of consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Basis for qualified conclusion
As explained in Note 4(3), the financial statements of non-significant consolidated subsidiaries and the information disclosed in Note 13 were based solely on the reports prepared by those subsidiaries which were not reviewed by independent auditors. Those statements reflect total assets of NT $4,651,145 thousand and NT $2,285,025 thousand, constituting 30% and 14% of the consolidated total assets, and total liabilities of NT $966,440 thousand and NT $1,084,650 thousand, constituting
~2~
17% and 15% of the consolidated total liabilities as at June 30, 2024 and 2023, respectively, and total comprehensive (loss) income of NT $34,055 thousand, NT($86,457) thousand, NT $74,563 thousand and NT($123,401) thousand, constituting 17%, (288%), 12% and (122%) of the consolidated total comprehensive income for the three-month and six-month periods then ended, respectively.
Qualified Conclusion
Except for the adjustments to the consolidated financial statements, if any, as might have been determined to be necessary had the financial statements of non-significant consolidated subsidiaries been reviewed by independent auditors, as described in the please italicize section above, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the Group as at June 30, 2024 and 2023, and its consolidated financial performance for the three-month and six-month periods then ended and its consolidated cash flows for the six-month periods then ended in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” that came into effect as endorsed by the Financial Supervisory Commission.
Chiang, Tsai-Yen Hsieh, Chih-Cheng For and on behalf of PricewaterhouseCoopers, Taiwan August 9, 2024
The accompanying consolidated financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying consolidated financial statements and independent auditors’ report are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.
As the financial statements are the responsibility of the management, PricewaterhouseCoopers, Taiwan cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.
~3~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS JUNE 30, 2024, DECEMBER 31, 2023 AND JUNE 30, 2023
(Expressed in thousands of New Taiwan dollars)
| Assets | Notes | June 30,2024 AMOUNT % $ 3,772,714 25 2,417,635 16 36,001 - 1,104,031 7 109,452 1 2,512 - 1,511,111 10 219,536 1 6,241 - 9,179,233 60 125,403 1 38,361 - 1,512,887 10 2,681,897 18 135,868 1 1,343,102 9 181,933 1 78,466 - 34,345 - 6,132,262 40 $ 15,311,495 100 |
December31,2023 AMOUNT % $ 5,798,794 38 390,169 2 28,796 - 1,741,007 11 68,885 - 1,298 - 1,762,109 11 342,470 2 4,072 - 10,137,600 64 124,007 1 38,461 - 1,083,803 7 2,614,119 17 144,286 1 1,326,463 8 164,789 1 173,077 1 35,953 - 5,704,958 36 $ 15,842,558 100 |
June 30,2023 | June 30,2023 |
|---|---|---|---|---|---|
| AMOUNT $ 3,772,714 2,417,635 36,001 1,104,031 109,452 2,512 1,511,111 219,536 6,241 9,179,233 125,403 38,361 1,512,887 2,681,897 135,868 1,343,102 181,933 78,466 34,345 6,132,262 $ 15,311,495 |
AMOUNT $ 5,798,794 390,169 28,796 1,741,007 68,885 1,298 1,762,109 342,470 4,072 10,137,600 124,007 38,461 1,083,803 2,614,119 144,286 1,326,463 164,789 173,077 35,953 5,704,958 $ 15,842,558 |
AMOUNT $ 6,062,081 387,860 46,726 1,624,152 58,081 6,397 1,808,796 490,246 4,841 10,489,180 107,600 71,545 948,103 2,615,156 155,069 1,335,498 272,365 177,927 39,158 5,722,421 $ 16,211,601 |
% | ||
| Current assets 1100 Cash and cash equivalents 1136 Current financial assets at amortised cost 1150 Notes receivable, net 1170 Accounts receivable, net 1200 Other receivables 1220 Current income tax assets 130X Inventories 1410 Prepayments 1470 Other current assets 11XX Current assets Non-current assets 1510 Non-current financial assets at fair value through profit or loss 1517 Non-current financial assets at fair value through other comprehensive income 1535 Non-current financial assets at amortised cost 1600 Property, plant and equipment 1755 Right-of-use assets 1760 Investment property 1780 Intangible assets 1840 Deferred income tax assets 1900 Other non-current assets 15XX Non-current assets 1XXX Total assets |
6(1) 6(4) 6(5) 6(5) 6(6) 6(2) 6(3) 6(4) 6(7) and 8 6(8) 6(9) and 8 6(10) |
38 3 - 10 - - 11 3 - |
|||
| 65 | |||||
| 1 - 6 16 1 8 2 1 - |
|||||
| 35 | |||||
| 100 |
(Continued)
~4~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS JUNE 30, 2024, DECEMBER 31, 2023 AND JUNE 30, 2023
(Expressed in thousands of New Taiwan dollars)
| June 30,2024 | December31,2023 | December31,2023 | June 30,2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities and Equity | Notes | AMOUNT | % | AMOUNT | % | AMOUNT | % | |||||||
| Current liabilities | ||||||||||||||
| 2100 | Short-term borrowings | 6(11) | $ | 1,617,044 | 11 | $ | 2,234,704 | 14 | $ | 2,244,191 | 14 | |||
| 2110 | Short-term notes and bills | 6(12) | ||||||||||||
| payable | - | - | - | - | 99,934 | 1 | ||||||||
| 2130 | Current contract liabilities | 6(22) | 191,253 | 1 | 351,051 | 2 | 455,805 | 3 | ||||||
| 2170 | Accounts payable | 1,044,253 | 7 | 1,240,588 | 8 | 1,470,145 | 9 | |||||||
| 2200 | Other payables | 6(14) | 999,578 | 6 | 917,502 | 6 | 1,015,253 | 6 | ||||||
| 2230 | Current income tax liabilities | 116,644 | 1 | 150,780 | 1 | 130,677 | 1 | |||||||
| 2250 | Provisions - current | 6(17) | 74,099 | - | 67,256 | - | 58,885 | - | ||||||
| 2280 | Current lease liabilities | 16,952 | - | 18,523 | - | 17,471 | - | |||||||
| 2320 | Long-term borrowings, current | 6(13) and 8 | ||||||||||||
| portion | 900,000 | 6 | - | - | - | - | ||||||||
| 2399 | Other current liabilities, others | 82,764 | 1 | 91,926 | 1 | 180,698 | 1 | |||||||
| 21XX | Current liabilities | 5,042,587 | 33 | 5,072,330 | 32 | 5,673,059 | 35 | |||||||
| Non-current liabilities | ||||||||||||||
| 2540 | Long-term borrowings | 6(13) and 8 | - | - | 900,000 | 6 | 900,000 | 5 | ||||||
| 2550 | Provisions - non-current | 6(17) | 124,032 | 1 | 130,998 | 1 | 135,009 | 1 | ||||||
| 2570 | Deferred income tax liabilities | 463,564 | 3 | 463,086 | 3 | 452,732 | 3 | |||||||
| 2580 | Non-current lease liabilities | 106,860 | 1 | 113,652 | 1 | 122,217 | 1 | |||||||
| 2600 | Other non-current liabilities | 40,787 | - | 39,726 | - | 40,257 | - | |||||||
| 25XX | Non-current liabilities | 735,243 | 5 | 1,647,462 | 11 | 1,650,215 | 10 | |||||||
| 2XXX | Total liabilities | 5,777,830 | 38 | 6,719,792 | 43 | 7,323,274 | 45 | |||||||
| Equity attributable to owners of | ||||||||||||||
| the parent | ||||||||||||||
| Share capital | 6(18) | |||||||||||||
| 3110 | Common stock | 2,788,000 | 18 | 2,788,000 | 18 | 2,788,000 | 17 | |||||||
| Capital surplus | 6(19) | |||||||||||||
| 3200 | Capital surplus | 2,053,174 | 13 | 2,046,394 | 13 | 2,046,394 | 13 | |||||||
| Retained earnings | 6(20) | |||||||||||||
| 3310 | Legal reserve | 1,512,604 | 10 | 1,484,678 | 9 | 1,484,678 | 9 | |||||||
| 3320 | Special reserve | 624,316 | 4 | 515,412 | 3 | 515,412 | 3 | |||||||
| 3350 | Unappropriated retained | |||||||||||||
| earnings | 2,408,173 | 16 | 2,584,914 | 16 | 2,395,965 | 15 | ||||||||
| Other equity interest | 6(21) | |||||||||||||
| 3400 | Other equity interest | ( | 228,834)( | 2)( | 624,316)( | 4)( | 580,305)( | 4) | ||||||
| 3500 | Treasury stocks | 6(18) | ( | 38,101) | - ( | 38,101) | - ( | 38,101) | - | |||||
| 31XX | Equity attributable to | |||||||||||||
| owners of the parent | 9,119,332 | 59 | 8,756,981 | 55 | 8,612,043 | 53 | ||||||||
| 36XX | Non-controlling interest | 414,333 | 3 | 365,785 | 2 | 276,284 | 2 | |||||||
| 3XXX | Total equity | 9,533,665 | 62 | 9,122,766 | 57 | 8,888,327 | 55 | |||||||
| 3X2X | Total liabilities and equity | $ | 15,311,495 | 100 | $ | 15,842,558 | 100 | $ | 16,211,601 | 100 |
The accompanying notes are an integral part of these consolidated financial statements.
~5~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
THREE-MONTH AND SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023
(Expressed in thousands of New Taiwan dollars, except earnings per share amount)
| Threemonths | Threemonths | Threemonths | ended June 30 | ended June 30 | Six months ended June 30 | Six months ended June 30 | Six months ended June 30 | Six months ended June 30 | Six months ended June 30 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Items | Notes | AMOUNT | % | AMOUNT | % | AMOUNT | % | AMOUNT | % | |||||||
| 4000 | Operating revenue | 6(22) | $ | 1,704,446 | 100 | $ | 2,208,835 | 100 | $ | 3,304,288 | 100 | $ | 4,462,412 | 100 | ||
| 5000 | Operating costs | 6(6)(27)(28) | ( | 1,159,865) ( | 68) | ( | 1,647,468) ( | 75) | ( | 2,274,168) ( | 69) | ( | 3,396,703) ( | 76) | ||
| 5900 | Net operating margin | 544,581 | 32 | 561,367 | 25 | 1,030,120 | 31 | 1,065,709 | 24 | |||||||
| Operating expenses | 6(27)(28) | |||||||||||||||
| 6100 | Selling and marketing expenses | ( | 40,332) ( | 2) | ( | 32,486) ( | 1) | ( | 67,747) ( | 2) | ( | 60,625) ( | 1) | |||
| 6200 | General and administrative | |||||||||||||||
| expenses | ( | 145,237) ( | 9) | ( | 129,145) ( | 6) | ( | 265,477) ( | 8) | ( | 254,030) ( | 6) | ||||
| 6300 | Research and development | |||||||||||||||
| expenses | ( | 263,207) ( | 15) | ( | 305,850) ( | 14) | ( | 522,000) ( | 16) | ( | 594,688) ( | 13) | ||||
| 6450 | Expected credit gain (loss) | 12(2) | ( | 150) | - | ( | 23) | - | 1,104 | - | ( | 238) | - | |||
| 6000 | Total operating expenses | ( | 448,926) ( | 26) | ( | 467,504) ( | 21) | ( | 854,120) ( | 26) | ( | 909,581) ( | 20) | |||
| 6900 | Operating profit | 95,655 | 6 | 93,863 | 4 | 176,000 | 5 | 156,128 | 4 | |||||||
| Non-operating income and expenses | ||||||||||||||||
| 7100 | Interest income | 6(23) | 56,312 | 3 | 54,858 | 3 | 104,447 | 3 | 91,553 | 2 | ||||||
| 7010 | Other income | 6(24) | 24,020 | 1 | 25,652 | 1 | 49,820 | 2 | 48,101 | 1 | ||||||
| 7020 | Other gains and losses | 6(25) | ( | 6,758) | - | ( | 8,691) | - | 1,755 | - | ( | 9,251) | - | |||
| 7050 | Finance costs | 6(26) | ( | 13,199) ( | 1) | ( | 16,679) ( | 1) | ( | 28,614) ( | 1) | ( | 32,965) ( | 1) | ||
| 7000 | Total non-operating income and | |||||||||||||||
| expenses | 60,375 | 3 | 55,140 | 3 | 127,408 | 4 | 97,438 | 2 | ||||||||
| 7900 | Profit before income tax | 156,030 | 9 | 149,003 | 7 | 303,408 | 9 | 253,566 | 6 | |||||||
| 7950 | Income tax expense | 6(29) | ( | 46,608) ( | 3) | ( | 52,795) ( | 3) | ( | 93,255) ( | 3) | ( | 83,623) ( | 2) | ||
| 8200 | Profit for the period | $ | 109,422 | 6 | $ | 96,208 | 4 | $ | 210,153 | 6 | $ | 169,943 | 4 | |||
| Other comprehensive income (loss) | ||||||||||||||||
| Components of other comprehensive | ||||||||||||||||
| income (loss) that will not be | ||||||||||||||||
| reclassified to profit or loss | ||||||||||||||||
| 8316 | Unrealised gain (loss) from | 6(3) | ||||||||||||||
| financial assets measured at fair | ||||||||||||||||
| value through other comprehensive | ||||||||||||||||
| loss | ($ | 1,102) | - | $ | 1,974 | - | ($ | 4,400) | - | $ | 1,658 | - | ||||
| Components of other comprehensive | ||||||||||||||||
| income (loss) that may be | ||||||||||||||||
| reclassified to profit or loss | ||||||||||||||||
| 8361 | Currency translation differences of | |||||||||||||||
| foreign operations | 111,089 | 7 | ( | 84,205) ( | 4) | 506,262 | 15 | ( | 87,126) ( | 2) | ||||||
| 8399 | Income tax relating to the | 6(29) | ||||||||||||||
| components of other | ||||||||||||||||
| comprehensive income (loss) that | ||||||||||||||||
| may be reclassified to profit or loss | ( | 21,763) ( | 1) | 16,046 | 1 | ( | 99,970) ( | 2) | 16,638 | - | ||||||
| 8360 | Components of other | |||||||||||||||
| comprehensive income (loss) | ||||||||||||||||
| that may be reclassified to profit | ||||||||||||||||
| or loss | 89,326 | 6 | ( | 68,159) ( | 3) | 406,292 | 13 | ( | 70,488) ( | 2) | ||||||
| 8300 | Total other comprehensive income | |||||||||||||||
| (loss) for the period | $ | 88,224 | 6 | ($ | 66,185) ( | 3) | $ | 401,892 | 13 | ($ | 68,830) ( | 2) | ||||
| 8500 | Total comprehensive income for the | |||||||||||||||
| period | $ | 197,646 | 12 | $ | 30,023 | 1 | $ | 612,045 | 19 | $ | 101,113 | 2 | ||||
| Profit, attributable to: | ||||||||||||||||
| 8610 | Owners of the parent | $ | 77,380 | 4 | $ | 91,969 | 4 | $ | 153,786 | 4 | $ | 158,325 | 4 | |||
| 8620 | Non-controlling interest | 32,042 | 2 | 4,239 | - | 56,367 | 2 | 11,618 | - | |||||||
| Profit for the period | $ | 109,422 | 6 | $ | 96,208 | 4 | $ | 210,153 | 6 | $ | 169,943 | 4 | ||||
| Comprehensive income attributable to: | ||||||||||||||||
| 8710 | Owners of the parent | $ | 163,334 | 10 | $ | 29,759 | 1 | $ | 549,268 | 17 | $ | 93,431 | 2 | |||
| 8720 | Non-controlling interest | 34,312 | 2 | 264 | - | 62,777 | 2 | 7,682 | - | |||||||
| Total comprehensive income for | ||||||||||||||||
| the period | $ | 197,646 | 12 | $ | 30,023 | 1 | $ | 612,045 | 19 | $ | 101,113 | 2 | ||||
| 9750 | Basic earnings per share (in | 6(30) | ||||||||||||||
| dollars) | $ | 0.28 | $ | 0.33 | $ | 0.56 | $ | 0.57 | ||||||||
| 9850 | Diluted earnings per share (in | 6(30) | ||||||||||||||
| dollars) | $ | 0.28 | $ | 0.33 | $ | 0.55 | $ | 0.57 |
The accompanying notes are an integral part of these consolidated financial statements.
~6~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023
(Expressed in thousands of New Taiwan dollars)
| Six-month period ended June 30, 2023 Balance at January 1, 2023 Profit for the period Other comprehensive income (loss) for the period Total comprehensive income (loss) Appropriation of 2022 earnings Legal reserve Special reserve Cash dividends Share-based payment transactions Retirement of employee restricted shares Difference between consideration and carrying amount of subsidiaries acquired Non-controlling interest Balance at June 30, 2023 Six-month period ended June 30, 2024 Balance at January 1, 2024 Profit for the period Other comprehensive income (loss) for the period Total comprehensive income (loss) Appropriation of 2023 earnings Legal reserve Special reserve Cash dividends Share-based payment transactions Changes in ownership interests in subsidiaries Non-controlling interest Balance at June 30, 2024 |
Notes | Equity attribu | Equity attribu | tableto owners of th | e parent | e parent | Non-controlling interest |
Totalequity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commonstock | Capitalsurplus | Retained earnings | Otherequityinterest | Treasury stocks |
Total | ||||||||||||||
| Legal reserve | Special reserve | Unappropriated retained earnings |
Currency translation differences of foreignoperations |
Other | |||||||||||||||
| 6(21) 6(20) 6(16)(21) 6(16)(18)(19)(21) 6(31) 6(21) 6(20) 6(16) 6(19) |
$2,788,180 - - - - - - - ( 180 ) - - $2,788,000 $2,788,000 - - - - - - - - - $2,788,000 |
$2,046,625 - - - - - - - ( 231 ) - - $2,046,394 $2,046,394 - - - - - - - 6,780 - $2,053,174 |
$1,441,002 - - - 43,676 - - - - - - $1,484,678 $1,484,678 - - - 27,926 - - - - - $1,512,604 |
$774,832 - - - - ( 259,420 ) - - - - - $515,412 $515,412 - - - - 108,904 - - - - $624,316 |
$ 2,366,630 158,325 - 158,325 ( 43,676 ) 259,420 ( 276,728 ) - - ( 68,006 ) - $ 2,395,965 $ 2,584,914 153,786 - 153,786 ( 27,926 ) ( 108,904 ) ( 193,697 ) - - - $ 2,408,173 |
($ 367,270 ) - ( 66,552 ) ( 66,552 ) - - - - - - - ($ 433,822 ) ($ 445,272 ) - 399,882 399,882 - - - - - - ($ 45,390 ) |
($148,837 ) - 1,658 1,658 - - - 285 411 - - ($146,483 ) ($179,044 ) - ( 4,400 ) ( 4,400 ) - - - - - - ($183,444 ) |
($38,101 ) - - - - - - - - - - ($38,101 ) ($38,101 ) - - - - - - - - - ($38,101 ) |
$8,863,061 158,325 ( 64,894 ) 93,431 - - ( 276,728 ) 285 - ( 68,006 ) - $8,612,043 $8,756,981 153,786 395,482 549,268 - - ( 193,697 ) - 6,780 - $9,119,332 |
$333,867 11,618 ( 3,936 ) 7,682 - - - - - ( 5,674 ) ( 59,591 ) $276,284 $365,785 56,367 6,410 62,777 - - - 15,102 ( 6,780 ) ( 22,551 ) $414,333 |
$9,196,928 169,943 ( 68,830 ) 101,113 - - ( 276,728 ) 285 - ( 73,680 ) ( 59,591 ) $8,888,327 $9,122,766 210,153 401,892 612,045 - - ( 193,697 ) 15,102 - ( 22,551 ) $9,533,665 |
The accompanying notes are an integral part of these consolidated financial statements.
~7~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023
(Expressed in thousands of New Taiwan dollars)
| CASH FLOWS FROM OPERATING ACTIVITIES Profit before tax Adjustments Adjustments to reconcile (profit) loss Depreciation Amortisation Expected credit (gain) loss Net loss on financial assets at fair value through profit or loss Interest expense Interest income Share-based payment compensation cost Gain on disposal of property, plant and equipment Changes in operating assets and liabilities Changes in operating assets Current contract assets Notes receivable Accounts receivable Other receivables Inventories Prepayments Other current assets Changes in operating liabilities Current contract liabilities Accounts payable Other payables Provisions Other current liabilities Other non-current liabilities Cash inflow generated from operations Interest received Interest paid Income tax paid Net cash flows from operating activities |
Six-month periods ended June 30 Notes 2024 2023 $ 303,408 $ 253,566 6(7)(8)(9)(27) 83,551 102,288 6(10)(27) 20,095 78,602 12(2) ( 1,104 ) 238 6(2)(25) 549 6,860 6(26) 28,614 32,965 6(23) ( 104,447 ) ( 91,553 ) 6(16) 15,102 285 6(25) ( 17 ) ( 11 ) - 21,033 ( 5,674 ) ( 45,641 ) 657,582 552,047 ( 10,700 ) ( 8,324 ) 334,719 573,550 98,799 ( 109,742 ) ( 1,943 ) 1,001 ( 161,597 ) 16,920 ( 248,547 ) ( 135,143 ) ( 143,215 ) ( 84,528 ) ( 307 ) 7,469 ( 10,792 ) 17,674 ( 488) ( 395) 853,588 1,189,161 78,336 89,010 ( 26,874 ) ( 28,009 ) ( 134,865) ( 43,190) 770,185 1,206,972 |
|---|---|
(Continued)
~8~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023
(Expressed in thousands of New Taiwan dollars)
| CASH FLOWS FROM INVESTING ACTIVITIES Acquisition of financial assets at fair value through profit or loss Proceeds from disposals of financial asset at fair value through profit or loss Acquisition of financial assets at amortised cost Proceeds from repayments of financial assets at amortised cost Proceeds from capital reduction of financial assets at fair value through other comprehensive income Acquisition of property, plant and equipment Proceeds from disposal of property, plant and equipment Acquisition of intangible assets Decrease (increase) in deposits paid Increase in deposits paid Net cash flows used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from short-term borrowings Repayment of short-term borrowings Proceeds from issuance of short-term notes and bills payable Repayment of short-term notes and bills payable Proceeds from long-term borrowings Repayment of long-term borrowings Increase in guarantee deposits received Decrease in guarantee deposits received Repayment of principal portion of lease liabilities Changes in non-controlling interest Net cash flows used in financing activities Effect of exchange rate Net (decrease) increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period |
Six-month periods ended June 30 Notes 2024 2023 $ - ($ 30,325 ) - 281 ( 2,752,670 ) ( 1,368,040 ) 409,813 970,867 1,607 2,323 6(32) ( 41,602 ) ( 44,335 ) 17 11 6(32) ( 3,829 ) ( 3,160 ) - ( 5,856 ) 1,961 - ( 2,384,703) ( 478,234) 6(33) 3,458,391 8,644,261 6(33) ( 4,081,000 ) ( 8,611,000 ) 6(33) - 1,097,985 6(33) - ( 1,400,000 ) 6(33) - 900,000 - ( 500,000 ) 6(33) 45 - 6(33) - ( 9 ) 6(33) ( 11,029 ) ( 10,051 ) ( 22,551) ( 133,271) ( 656,144) ( 12,085) 244,582 ( 14,045) ( 2,026,080 ) 702,608 6(1) 5,798,794 5,359,473 6(1) $ 3,772,714 $ 6,062,081 |
|---|---|
The accompanying notes are an integral part of these consolidated financial statements.
~9~
ALTEK CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023
(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)
1. HISTORY AND ORGANIZATION
Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Act of the Republic of China (R.O.C.). The Company and its subsidiaries (collectively referred herein as the “Group”) are primarily engaged in the development, manufacturing and sale of automobile cameras, medical and digital image technology application products, and related export and import trade.
The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.
- THE DATE OF AUTHORISATION FOR ISSUANCE OF THE CONSOLIDATED FINANCIAL
STATEMENTS AND PROCEDURES FOR AUTHORISATION
These consolidated financial statements were reported to the Board of Directors and issued on August 9, 2024.
3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS
- (1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRS”) Accounting Standards that came into effect as endorsed by the Financial Supervisory Commission (“FSC”)
New standards, interpretations and amendments endorsed by FSC and become effective from 2024 are as follows:
| are as follows: | |
|---|---|
| New Standards,Interpretations and Amendments | Effective date by International Accounting Standards Board ("IASB") |
| Amendments to IFRS 16, ‘Lease liability in a sale and leaseback’ Amendments to IAS 1, ‘Classification of liabilities as current or non-current’ Amendments to IAS 1, ‘Non-current liabilities with covenants’ Amendments to IAS 7 and IFRS 7, ‘Supplier finance arrangements’ |
January 1, 2024 January 1, 2024 January 1, 2024 January 1, 2024 |
The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.
~10~
(2) Effect of new issuances of or amendments to IFRS Accounting Standards as endorsed by the FSC
but not yet adopted by the Group
New standards, interpretations and amendments endorsed by the FSC effective from 2025 are as follows:.
| follows:. | |
|---|---|
| Effective date by | |
| New Standards,InterpretationsandAmendments | IASB |
| Amendments to IAS 21, ‘Lack of exchangeability’ | January 1, 2025 |
| The above standards and interpretations have no significant impact to the Group’s financial condition | |
| and financial performance based on the Group’s assessment. |
(3) IFRS Accounting Standards issued by IASB but not yet endorsed by the FSC
New standards, interpretations and amendments issued by IASB but not yet included in the IFRS Accounting Standards as endorsed by the FSC are as follows:
| New Standards,InterpretationsandAmendments | Effective date by IASB |
|---|---|
| Amendments to IFRS 9 and IFRS 7, ‘Amendments to the classification and measurement of financial Instruments’ Amendments to IFRS 10 and IAS 28, ‘Sale or contribution of assets between an investor and its associate or joint venture’ IFRS 17, ‘Insurance contracts’ Amendments to IFRS 17, ‘Insurance contracts’ Amendment to IFRS 17, ‘Initial application of IFRS 17 and IFRS 9 – comparative information’ IFRS 18, ‘Presentation and disclosure in financial statements’ IFRS 19, ‘Subsidiaries without public accountability: disclosures’ Annual Improvements to IFRS Accounting Standards—Volume 11 |
January 1, 2026 To be determined by IASB January 1, 2023 January 1, 2023 January 1, 2023 January 1, 2027 January 1, 2027 January 1, 2026 |
Except for the following, the above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.
- A. Amendments to IFRS 9 and IFRS 7, ‘Amendments to the classification and measurement of financial instruments’
The IASB issued the amendments to:
Update the disclosures for equity instruments designated at fair value through other comprehensive income (FVOCI). The entity shall disclose the fair value of each class of investment and is no longer required to disclose the fair value of each investment. In addition, the amendments require the entity to disclose the fair value gain or loss presented in other comprehensive income during the period, showing separately the fair value gain or loss related to investments derecognised during the reporting period and the fair value gain or loss related to investments held at the end of the reporting period; and any transfers of the cumulative gain or loss within equity related to the investments derecognised during that reporting period.
~11~
-
B. IFRS 18, ‘Disclosure and presentation of financial statements’
-
IFRS 18, ‘Disclosure and presentation of financial statements’ replaces IAS 1 and updates the structure of the consolidated comprehensive income statement, adds disclosure of management performance measures, and strengthens the summary and segmentation principles applied to the major financial statements and notes.
4. SUMMARY OF MATERIAL ACCOUNTING POLICIES
The principal accounting policies adopted are consistent with Note 4 in the consolidated financial statements for the year ended December 31, 2023, except for the compliance statement, basis of preparation, basis of consolidation and additional policies as set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.
(1) Compliance statement
-
A. The consolidated financial statements of the Group have been prepared in accordance with the Rules Governing the Preparation of Financial Statements by Securities Issuers and IAS 34, ‘Interim financial reporting’ that came into effect as endorsed by the FSC.
-
B. The consolidated financial statements should be read together with the 2023 consolidated financial statements.
(2) Basis of preparation
-
A. Except for the following items, the consolidated financial statements have been prepared under the historical cost convention:
-
(a) Financial assets (including derivative instruments) at fair value through profit or loss.
-
(b) Financial assets at fair value through other comprehensive income.
-
(c) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.
-
B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the FSC (collectively referred herein as the “IFRSs”) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 5.
(3) Basis of consolidation
-
A. Basis for preparation of consolidated financial statements:
-
Basis for preparation of consolidated financial statements is consistent with the 2023 consolidated financial statements.
-
B. Subsidiaries included in the consolidated financial statements:
~12~
| Name of Investor | Name ofSubsidiaries | Main BusinessActivities | Ownership (%) | Note | ||
|---|---|---|---|---|---|---|
| June 30,2024 100 100 100 100 69.87 100 100 100 100 - 100 100 100 100 100 100 75 100 100 100 100 100 100 100 100 er 1, 2023. of an significant subsidiary fr |
December31,2023 100 100 100 100 75.11 100 100 100 100 100 100 100 100 100 100 100 75 100 100 100 100 100 100 100 100 om 2024, the financial state |
June 30,2023 | ||||
| Altek Corporation Altek International Investment Co., Ltd. Investments " Altek Japan Corporation Buying and selling of electronic components " Altek International Holding (BVI) Co., Ltd. Investments " Altek Investment Corporation Investments " Altek Medical Pte. Ltd. Research and development, sales of medical electronic equipment and investment Altek International Investment Co., Ltd. Altek Lab Inc. Collection of American digital imaging technology information and design services " Altek Semiconductor (Cayman) Co., Ltd. Investments " Altek Optical Technology (Cayman) Co., Ltd. Investments " Altek International Trading Co., Ltd. Intercompany transactions Altek Investment Corporation Ptek Corporation Product development and design Note 1 Altek (Kunshan) Co., Ltd. Manufacture and sales of digital still camera and its accessories Note 1 Jia Jing Business Management (Kunshan) Co., Ltd. Business management and non-residential real estate leasing Note 1 Hong Jing Business Management (Kunshan) Co., Ltd. Business management, housing leasing and property management Note 1 Altek EMS (Kunshan) Co., Ltd. Production /sales of electronic product components Note 1 Altek Precision (Kunshan) Co., Ltd. Manufacture and sales of digital camera parts Note 1 Altek Trading (Shanghai) Limited Wholesale, import and export of related electronic and their associated accessories Altek Optical Technology (Cayman) Co., Ltd. Altek Optical Technology (Kunshan) Co., Ltd. Manufacture and sales of photo electron device, optical instrument, camera and equipment Altek Semiconductor (Cayman) Co., Ltd. Altek Semiconductor Corporation Research design and sales of ASIC Altek Trading (Shanghai) Limited Altek Semiconductor (Shanghai) Co., Ltd. Research design and sales of imaging technologies, electronic software and hardware Altek Medical Pte. Ltd. Altek Biotechnology Corporation Research and development, manufacture and sales of medical electronic equipments " Altek Medical (HongKong) Limited Investments " Altek Biotechnology Pte. Ltd. Research and development and sales of medical electronic equipments " Altek Medical Sdn. Bhd. Manufacture and sales of medical electronic equipments Altek Medical (HongKong) Limited Altek Medical (Shanghai) Limited Sales of medical electronic equipments Altek Medical (Shanghai) Limited Altek Medical (Kunshan) Limited Manufacture and sales of medical electronic equipments Note 1: Invested by Leading Tech. Co., Ltd., Toptek Investment Cayman Co., Ltd., Altek Trading (Cayman) Co., Ltd., which are wholly owned by Altek International Investment Co., Ltd. Note 2: Ptek Corporation was dissolved and liquidated on October 24, 2022 by the resolution of its board of directors, and dissolved with the approval of the competent authority on Novemb Note 3: Altek Medical Holding (Cayman) Co., Ltd. relocated to Singapore on April 13, 2023, and changed its name to Altek Medical Pte. Ltd. Note 4: The Group's ownership decreased due to the issuance of restricted shares to employee by the subsidiary. Note 5: It was established by Altek (Kunshan) Co., Ltd. by business division on December 19, 2023. Note 6:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2024 and 2023 were not reviewed by independent auditors. Note 7:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2023 were not reviewed by independent auditors. Note 8:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2024 were not reviewed by independent auditors. Note 9: In 2023, it meets the definition of an significant subsidiary, the financial statements as of June 30, 2023 were reviewed by independent auditors. Since it does not meet the definition were not been reviewed by independent auditors. |
100 100 100 100 77.70 100 100 100 100 100 100 - - 100 100 100 75 100 100 100 100 100 100 100 100 ments as of June 30, 2024 |
- Note 6 Note 9 Note 6 Note 3 Note 4 Note 6 Note 6 Note 6 Note 6 Note 2 Note 7 - Note 5 Note 8 Note 5 Note 8 Note 6 Note 6 Note 6 Note 6 Note 6 Note 6 Note 3 Note 3 Note 6 Note 3 Note 6 Note 3 Note 6 Note 6 Note 6 |
~13~
-
C. Subsidiaries not included in the consolidated financial statements: None.
-
D. Adjustments for subsidiaries with different balance sheet dates: None.
-
E. Significant restrictions: None.
-
F. Subsidiaries that have non-controlling interests that are material to the Group: None.
(4) Employee benefits
Pension-Defined benefit plans
Pension cost for the interim period is calculated on a year-to-date basis by using the pension cost rate derived from the actuarial valuation at the end of the prior financial year, adjusted for significant market fluctuations since that time and for significant curtailments, settlements, or other significant one-off events. And, the related information is disclosed accordingly.
(5) Income tax
The interim period income tax expense is recognised based on the estimated average annual effective income tax rate expected for the full financial year applied to the pretax income of the interim period, and the related information is disclosed accordingly.
5. CRITICAL ACCOUNTING JUDGEMENTS, ESTIMATES AND KEY SOURCES OF ASSUMPTION
UNCERTAINTY
There have been no significant changes during the period. Please refer to Note 5 in the consolidated financial statements for the year ended December 31, 2023.
6. DETAILS OF SIGNIFICANT ACCOUNTS
(1) Cash and cash equivalents
| Cash on hand Checking and demand accounts Time deposits Total |
June 30,2024 December31,2023 1,443 $ 1,283 $ 1,306,636 1,531,317 2,464,635 4,266,194 3,772,714 $ 5,798,794 $ |
June 30,2023 |
|---|---|---|
| 1,896 $ 2,058,726 4,001,459 |
||
| 6,062,081 $ |
-
A. The Group transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.
-
B. The Group has no cash and cash equivalents pledged to others.
(2) Financial assets at fair value through profit or loss
| Asset Items Non-current items: Financial assets mandatorily measured at fair value through profit or loss Unlisted stocks Hybrid instruments Valuation adjustment Total |
June 30,2024 December31,2023 10,312 $ 10,312 $ 32,450 30,705 82,641 82,990 125,403 $ 124,007 $ |
June 30,2023 |
|---|---|---|
| 10,312 $ 31,140 66,148 |
||
| 107,600 $ |
~14~
- A. Amounts recognised in profit or loss in relation to financial assets at fair value through profit or loss are listed below:
| loss are listed below: | ||||
|---|---|---|---|---|
| Three-month | Three-month | |||
| period ended June 30, | 2024 | period | ended June 30,2023 | |
| Equity instruments | ($ | 519) |
($ | 12,597) |
| Derivatives | - | ( | 94) |
|
| Total | ($ | 519) | ($ | 12,691) |
| Six-month | Six-month | |||
| period ended June 30, | 2024 | period | ended June 30,2023 | |
| Equity instruments | ($ | 549) |
($ | 7,141) |
| Derivatives | - | 281 | ||
| Total | ($ | 549) | ($ | 6,860) |
- B. The Group has no financial assets measured at fair value through profit and loss as at June 30, 2024, December 31, 2023, and June 30, 2023, pledged to others.
(3) Financial assets at fair value through other comprehensive income
| Items Non-current items: Equity instruments Unlisted stocks Valuation adjustment Total |
June 30,2024 December31,2023 221,806 $ 217,506 $ 183,445) ( 179,045) ( ( 38,361 $ 38,461 $ |
June 30,2023 218,029 $ 146,484) 71,545 $ |
|---|---|---|
-
A. The Group has elected to classify equity instruments that are considered to be strategic investments as financial assets at fair value through other comprehensive income. The fair value of such investments amounted to $38,361, $38,461 and $71,545 as at June 30, 2024, December 31, 2023, and June 30, 2023, respectively.
-
B. Amounts recognised in other comprehensive income in relation to the financial assets at fair value through other comprehensive income (loss) amounted to ($1,102), $1,974, ($4,400) and $1,658 for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.
-
C. The Group has no financial assets at fair value through other comprehensive income as at June 30, 2024, December 31, 2023, and June 30, 2023, pledged to others.
~15~
(4) Financial assets at amortised cost
| Financial assets at amortised cost | ||
|---|---|---|
| Items Current items: Time deposit with maturity from three months to one year Non-current items: Corporate bonds Time deposit with maturity over one year |
June 30,2024 December31,2023 2,417,635 $ 390,169 $ 283,513 $ - $ 1,229,374 1,083,803 1,512,887 $ 1,083,803 $ |
June 30,2023 |
| 387,860 $ |
||
| - $ 948,103 |
||
| 948,103 $ |
- A. Amounts recognised in profit or loss in relation to financial assets at amortised cost are listed below:
| below: | ||
|---|---|---|
| Interest income Interest income |
Three-month period ended June 30,2024 36,043 $ Six-month period ended June 30,2024 58,141 $ |
Three-month period ended June 30,2023 |
| 9,645 $ |
||
| Six-month period ended June 30,2023 |
||
| 17,623 $ |
-
B. The Group has no financial assets at amortised cost pledged to others.
-
C. Information relating to credit risk of financial assets at amortised cost is provided in Note 12(2). The counterparties of the Group’s investments in time deposits are financial institutions with high credit quality, so the Group expects that the probability of counterparty default is remote.
(5) Notes and accounts receivable
| Notes receivable Accounts receivable Less: Loss allowance |
June 30,2024 December31,2023 36,001 $ 28,796 $ 1,104,426 $ 1,742,473 $ 395) ( 1,466) ( ( 1,104,031 $ 1,741,007 $ |
June 30,2023 46,726 $ 1,624,846 $ 694) 1,624,152 $ |
|---|---|---|
~16~
A. The ageing analysis of notes and accounts receivable based on past due date is as follows:
| Not past due Up to 30 days 31 to 90 days 91 to 180 days 181 to 360 days |
Notes Accounts receivable receivable 36,001 $ 1,050,378 $ - 52,063 - 1,178 - 807 - - 36,001 $ 1,104,426 $ June 30,2024 |
December | Accounts receivable 1,449,054 $ 282,269 10,260 208 682 1,742,473 $ 31,2023 |
June 30,2023 | June 30,2023 |
|---|---|---|---|---|---|
| Notes receivable 36,001 $ - - - - 36,001 $ |
Notes receivable 28,796 $ - - - - 28,796 $ |
Notes receivable 46,726 $ - - - - 46,726 $ |
Accounts receivable |
||
| 1,408,269 $ 194,519 21,851 207 - |
|||||
| 1,624,846 $ |
The above ageing analysis was based on past due date.
-
B. As of June 30, 2024, December 31, 2023, and June 30, 2023, accounts receivable were all from contracts with customers. And as of January 1, 2023, the balance of accounts receivable from contracts with customers amounted to $2,179,250.
-
C. The Group’s notes receivable and accounts receivable do not hold any collateral provided by customers.
-
D. As at June 30, 2024, December 31, 2023, and June 30, 2023, without taking into account any collateral held or other credit enhancements, the maximum exposure to credit risk in respect of the amount that best represents the Group’s notes and accounts receivable was $36,001, $28,796 and $46,726; $1,104,031, $1,741,007 and $1,624,152, respectively.
-
E. Information relating to credit risk of notes and accounts receivable are provided in Note 12(2).
(6) Inventories
| Raw materials Work in progress Finished goods Total Raw materials Work in progress Finished goods Total |
June 30,2024 | ||
|---|---|---|---|
| Cost 1,155,500 $ 243,815 195,338 1,594,653 $ |
Allowance for valuation loss 43,510) ($ 28,737) ( 11,295) ( 83,542) ($ December31,2023 |
Bookvalue | |
| 1,111,990 $ 215,078 184,043 |
|||
| 1,511,111 $ |
|||
| Cost 1,201,372 $ 301,734 340,901 1,844,007 $ |
Bookvalue | ||
| 1,152,653 $ 279,778 329,678 |
|||
| 1,762,109 $ |
~17~
| Raw materials Work in progress Finished goods Total |
June 30,2023 | ||
|---|---|---|---|
| Cost 1,304,761 $ 321,687 224,298 1,850,746 $ |
Allowance for valuation loss 24,822) ($ 7,762) ( 9,366) ( 41,950) ($ |
Bookvalue | |
| 1,279,939 $ 313,925 214,932 |
|||
| 1,808,796 $ |
The cost of inventories recognised as expense for the period:
| Cost of goods sold and others (Gain on reversal of) loss on decline in market value Total Cost of goods sold and others (Gain on reversal of) loss on decline in market value Total |
Three-month period ended June 30,2024 1,147,475 $ 12,390 ( 1,159,865 $ Six-month period ended June 30,2024 2,272,524 $ 1,644 ( 2,274,168 $ |
Three-month period ended June 30,2023 1,652,545 $ 5,077) 1,647,468 $ Six-month period ended June 30,2023 3,420,144 $ 23,441) 3,396,703 $ |
|---|---|---|
For the three-month and six-month periods ended June 30, 2023, the Group reversed a previous inventory write-down and accounted for as reduction of cost of goods sold because inventory that has been appropriated as loss on decline in market value was partially sold.
(Blank below)
~18~
(7) Property, plant and equipment
| At January 1 Cost Accumulated depreciation At January 1 Additions Reclassifications Depreciation charge Net exchange differences At June 30 At June 30 Cost Accumulated depreciation |
2024 | |||
|---|---|---|---|---|
~19~
2023
| At January 1 Cost Accumulated depreciation At January 1 Additions Reclassifications Depreciation charge Net exchange differences At June 30 At June 30 Cost Accumulated depreciation |
Construction in progress and Buildings and equipment to Land structures Machinery Test equipment be inspected Others Total 468,684 $ 2,768,758 $ 1,102,114 $ 138,366 $ 25,538 $ 398,066 $ 4,901,526 $ - 896,745) ( 845,228) ( 126,535) ( - 370,685) ( 2,239,193) ( 468,684 $ 1,872,013 $ 256,886 $ 11,831 $ 25,538 $ 27,381 $ 2,662,333 $ 468,684 $ 1,872,013 $ 256,886 $ 11,831 $ 25,538 $ 27,381 $ 2,662,333 $ - 123 1,846 473 40,222 3,558 46,222 7,599 1,825 4,684 344 6,964) ( - 7,488 - 34,948) ( 37,233) ( 2,256) ( - 4,900) ( 79,337) ( - 15,486) ( 4,947) ( 24) ( 742) ( 351) ( 21,550) ( 476,283 $ 1,823,527 $ 221,236 $ 10,368 $ 58,054 $ 25,688 $ 2,615,156 $ 476,283 $ 2,745,304 $ 1,085,169 $ 137,557 $ 58,054 $ 260,181 $ 4,762,548 $ - 921,777) ( 863,933) ( 127,189) ( - 234,493) ( 2,147,392) ( 476,283 $ 1,823,527 $ 221,236 $ 10,368 $ 58,054 $ 25,688 $ 2,615,156 $ |
|---|---|
- A. For the six-month periods ended June 30, 2024 and 2023, there was no capitalisation of borrowing costs attributable to the property, plant and equipment.
B. Information about the property, plant and equipment that were pledged to others as collaterals is provided in Note 8.
~20~
- (8) Leasing arrangements lessee
-
A. The Group leases various assets including land, buildings, and business vehicles, the duration of the building and the business vehicles lease contract is usually between 1 and 5 years, the duration of the land lease contract usually between 20 and 49 years. Lease agreements are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose covenants, but leased assets may not be used as security for borrowing purposes.
-
B. Short-term leases with a lease term of 12 months or less comprise of buildings and equipment. Low-value assets comprise of copy machines, etc.
-
C. The carrying amount and depreciation charge are as follows:
| June 30,2024 December31,2023 June 30,2023 Land 98,505 $ 99,502 $ 101,259 $ Buildings 37,363 44,784 53,236 Transportation equipment (Business vehicles) - - 574 135,868 $ 144,286 $ 155,069 $ Carryingamount Three-month Three-month period ended period ended June 30,2024 June 30,2023 Land 939 $ 933 $ Buildings 4,429 3,861 Transportation equipment (Business vehicles) - 859 5,368 $ 5,653 $ Six-month Six-month period ended period ended June 30,2024 June 30,2023 Land 1,873 $ 1,868 $ Buildings 8,763 6,616 Transportation equipment (Business vehicles) - 1,720 10,636 $ 10,204 $ Depreciationcharge Depreciationcharge |
Carryingamount | Carryingamount | |
|---|---|---|---|
| June 30,2023 | |||
| 101,259 $ 53,236 574 |
|||
| 155,069 $ |
|||
| Three-month Three-month period ended period ended June 30,2024 June 30,2023 939 $ 933 $ 4,429 3,861 - 859 5,368 $ 5,653 $ Depreciationcharge |
Three-month period ended June 30,2023 |
||
| 933 $ 3,861 859 |
|||
| 5,653 $ |
|||
| Six-month period ended June 30,2024 1,873 $ 8,763 - 10,636 $ |
Six-month period ended June 30,2023 |
||
| 1,868 $ 6,616 1,720 |
|||
| 10,204 $ |
- D. For the three-month and six-month periods ended June 30, 2024 and 2023, the additions to rightof-use assets were $0, $31,174, $0 and $37,682, respectively.
~21~
E. The information on profit and loss accounts relating to lease agreements is as follows:
| Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease agreements Expense on leases of low-value assets Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease agreements Expense on leases of low-value assets |
Three-month period ended June 30,2024 617 $ 1,068 50 Six-month period ended June 30,2024 1,246 $ 1,904 109 |
Three-month period ended June 30,2023 |
|---|---|---|
| 567 $ 1,418 64 Six-month period ended June 30,2023 |
||
| 907 $ 2,710 157 |
-
F. For the six-month periods ended June 30, 2024 and 2023, the Group’s total cash outflow for leases were $13,042 and $12,918, respectively.
-
G. Extension and termination options
In determining the lease term, the Group takes into consideration all facts and circumstances that create an economic incentive to exercise an extension option. The assessment of lease period is reviewed if a significant event occurs which affects the assessment.
(9) Investment property
| nvestment property | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024 | |||||||||
| Land | Buildings | and structures | Total | ||||||
| At January 1 | |||||||||
| Cost | $ | 587,193 |
$ | 1,048,977 |
$ | 1,636,170 |
|||
| Accumulated depreciation | ( | 4,743) |
( | 304,964) |
( | 309,707) |
|||
| $ | 582,450 | $ | 744,013 | $ | 1,326,463 | ||||
| At January 1 | $ | 582,450 |
$ | 744,013 |
$ | 1,326,463 |
|||
| Depreciation charge | ( | 153) |
( | 12,752) |
( | 12,905) |
|||
| Net exchange differences | 447 | 29,097 | 29,544 | ||||||
| At June 30 | $ | 582,744 | $ | 760,358 | $ | 1,343,102 | |||
| At June 30 | |||||||||
| Cost | $ | 587,880 |
$ | 1,089,389 |
$ | 1,677,269 |
|||
| Accumulated depreciation | ( | 5,136) |
( | 329,031) |
( | 334,167) |
|||
| $ | 582,744 | $ | 760,358 | $ | 1,343,102 |
~22~
2023
| 2023 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Land | Buildingsand structures | Total | |||||||
| At January 1 | |||||||||
| Cost | $ | 587,427 |
$ | 1,062,736 |
$ | 1,650,163 |
|||
| Accumulated depreciation | ( | 4,522) |
( | 283,594) |
( | 288,116) |
|||
| $ | 582,905 | $ | 779,142 | $ | 1,362,047 | ||||
| At January 1 | $ | 582,905 |
$ | 779,142 |
$ | 1,362,047 |
|||
| Depreciation charge | ( | 151) |
( | 12,596) |
( | 12,747) |
|||
| Net exchange differences | ( | 209) |
( | 13,593) |
( | 13,802) |
|||
| At June 30 | $ | 582,545 | $ | 752,953 | $ | 1,335,498 | |||
| At June 30 | |||||||||
| Cost | $ | 587,112 |
$ | 1,044,222 |
$ | 1,631,334 |
|||
| Accumulated depreciation | ( | 4,567) |
( | 291,269) |
( | 295,836) |
|||
| $ | 582,545 | $ | 752,953 | $ | 1,335,498 |
- A. Rental income from investment property and direct operating expenses arising from investment property are shown below:
| Rental income from investment property Direct operating expenses arising from the investment property that generated rental income during the period Rental income from investment property Direct operating expenses arising from the investment property that generated rental income during the period |
Three-month period ended June 30,2024 28,732 $ 9,323 $ Six-month period ended June 30,2024 56,958 $ 18,512 $ |
Three-month period ended June 30,2023 |
|---|---|---|
| 24,339 $ |
||
| 8,686 $ |
||
| Six-month period ended June 30,2023 |
||
| 49,022 $ |
||
| 17,490 $ |
-
B. The fair value of the investment property held by the Group as at June 30, 2024, December 31, 2023, and June 30, 2023, amounted to $1,811,114, $1,800,394 and $1,838,038, respectively, which were valued by independent appraisers. Valuations were made using the comparative method and income approach to perform evaluation capitalisation.
-
C. There was no capitalisation of borrowing costs attributable to investment property.
-
D. Information about the investment property that was pledged to others as collateral is provided in Note 8.
~23~
(10) Intangible assets
| 2024 | 2023 | |||||
|---|---|---|---|---|---|---|
| At January 1 | ||||||
| Cost | $ | 638,166 |
$ | 742,377 |
||
| Accumulated amortisation | ( | 473,377) |
( | 428,874) |
||
| $ | 164,789 | $ | 313,503 | |||
| At January 1 | $ | 164,789 |
$ | 313,503 |
||
| Additions | 4,983 | 36,725 | ||||
| Reclassifications | 28,007 | - | ||||
| Amortisation charge | ( | 20,095) |
( | 78,602) |
||
| Net exchange differences | 4,249 | 739 | ||||
| At June 30 | $ | 181,933 | $ | 272,365 | ||
| At June 30 | ||||||
| Cost | $ | 261,965 |
$ | 556,881 |
||
| Accumulated amortisation | ( | 80,032) |
( | 284,516) |
||
| $ | 181,933 | $ | 272,365 | |||
| A. Details of amortisation on intangible assets are as follows: | ||||||
| Three-month | Three-month | |||||
| period ended June 30,2024 | period | ended June 30,2023 | ||||
| Operating costs | $ | 155 |
$ | 149 |
||
| Operating expenses | 10,837 | 39,487 | ||||
| $ | 10,992 | $ | 39,636 | |||
| Six-month | Six-month | |||||
| period ended June 30,2024 | period | ended June 30,2023 | ||||
| Operating costs | $ | 305 |
$ | 307 |
||
| Operating expenses | 19,790 | 78,295 | ||||
| $ | 20,095 | $ | 78,602 |
B. The Group has no intangible assets pledged to others.
(11) Short-term borrowings
| Short-term borrowings | |||
|---|---|---|---|
| Type ofborrowings Bank borrowings Unsecured borrowings Type ofborrowings Bank borrowings Unsecured borrowings Type ofborrowings Bank borrowings Unsecured borrowings |
June 30,2024 1,617,044 $ December31,2023 2,234,704 $ June 30,2023 2,244,191 $ |
Interest raterange 1.78% ~ 2.90% Interest raterange 1.74%~3.10% Interest raterange 1.75%~3.10% |
Collateral |
| None Collateral |
|||
| None Collateral |
|||
| None |
~24~
(12) Short-term notes and bills payable
| June 30, | 2024 | December31,2023 | December31,2023 | December31,2023 | June 30,2023 | June 30,2023 | |
|---|---|---|---|---|---|---|---|
| Commercial paper payable | $ | - |
$ | - |
$ | 100,000 |
|
| Less: Discount on short-term | |||||||
| notes and bills payable | - | - | ( | 66) | |||
| $ | - | $ | - | $ | 99,934 | ||
| Interest rate range | - | - | 1.80%~1.90% | ||||
| Long-term borrowings | |||||||
| Interest | |||||||
| Type ofborrowings | Borrowing period | rate | range | Collateral | June | 30,2024 | |
| Bank secured borrowings | June 9, 2023 to June 9, | 1.9%~2.0% | Note | $ | 900,000 |
||
| 2025 | |||||||
| Less: Current portion | ( | 900,000) |
|||||
| $ | - | ||||||
| Interest | |||||||
| Type ofborrowings | Borrowing period | rate | range | Collateral | December31,2023 | ||
| Bank secured borrowings | June 9, 2023 to June 9, | 1.9%~2.0% | Note | $ | 900,000 |
||
| 2025 | |||||||
| Less: Current portion | - | ||||||
| $ | 900,000 | ||||||
| Interest | |||||||
| Type ofborrowings | Borrowing period | rate | range | Collateral | June | 30,2023 | |
| Bank secured borrowings | June 9, 2023 to June 9, | 1.9%~2.0% | Note | $ | 900,000 |
||
| 2025 | |||||||
| Less: Current portion | - | ||||||
| $ | 900,000 |
- (13) Long term borrowings
Note:For details of the collateral of long-term borrowings, please refer to Note 8.
~25~
(14) Other payables
| Accrued salaries and bonus Cash dividends payable Employees’ and directors’ compensation payable Royalty payable Taxes payable Insurance premiums and pensions payable Service fee payable Interest payable Payable on equipment Payable on intangible assets Other |
June 30,2024 December31,2023 183,246 $ 267,240 $ 193,697 - 301,068 346,960 1,225 1,189 31,443 29,487 14,709 16,068 68,847 75,240 2,991 2,492 17,364 329 43,772 42,618 141,216 135,879 999,578 $ 917,502 $ |
June 30,2023 |
|---|---|---|
| 185,779 $ 276,728 269,313 1,254 34,997 16,316 56,877 3,756 2,844 44,251 123,138 |
||
| 1,015,253 $ |
(15) Pensions
-
A. (a) The Company has a defined benefit pension plan in accordance with the Labor Standards Act, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Labor Standards Act. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The company contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee.
-
(b) For the aforementioned pension plan, the Group recognised pension costs of $0, $0, $40 and
- $64 for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.
-
(c) Expected contributions to the defined benefit pension plans of the Company for the year ending December 31, 2024 amount to $1,385.
-
B.(a) Effective July 1, 2005, the Company and its domestic subsidiaries have established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act, covering all regular employees with R.O.C. nationality. Under the New Plan, the Company and its domestic subsidiaries contribute monthly an amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. The pension costs under defined contribution pension plans of the Group for the three-month and six-month periods ended June 30, 2024 and 2023, were $7,379, $8,025, $14,922 and $16,341,
~26~
respectively, under the above pension scheme.
- (b) The foreign subsidiaries provided defined contribution plans for their employees. Pursuant to local regulations, such employees and the subsidiaries each make contributions based on a certain percentage based of the salaries and wages to the pension funds. The subsidiaries had recognised pension costs of $6,873, $6,079, $13,439 and $12,725, for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.
(16) Share-based payments
- A. For the six-month periods ended June 30, 2024 and 2023, the Group’s share-based payment arrangements were as follows:
| Type of arrangement | Grant date | Quantity granted (share in thousands) |
Contract period |
Vesting conditions |
|---|---|---|---|---|
| Plan for restricted shares to employee (2018-1) Plan for restricted shares to employee (2019-1) " |
January 20, 2020 January 20, 2020 April 24, 2020 |
2,196 2,030 86 |
3 years 3 years 3 years |
Note Note Note |
-
Note: The restricted shares were issued at no consideration to the Company’s existing employees whose service years have reached 1 year, 2 years and 3 years and who achieved the performance condition. The vested ratio is 40%, 30% and 30%, respectively. If employees who are entitled to receive restricted shares do not meet the vesting conditions, the Company will retrieve at no consideration and retire those shares. The shares and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the shares and dividends if they resign during the vesting period.
-
B. Restricted shares to employees:
The information on restricted shares to employees is as follows (share in thousands): For the six-month period ended June 30, 2024: None.
| 2023 | |||
|---|---|---|---|
| Shares not vested beginning balance | 912 | ||
| Shares vested | ( | 894) |
|
| Shares forfeited - retired | ( | 18) |
|
| Shares not vested ending balance | - |
~27~
- C. The information of fair value of the share-based payment transaction given by the Group is as follows:
| follows: | ||||||||
|---|---|---|---|---|---|---|---|---|
| Type of arrangement | Grant date | Share price (in NT dollar) |
Exercise price (in NT dollar) |
Expected price volatility |
Expected option life |
Expected dividends |
Risk-free interest rate |
Weighted average fair value per unit (in NT dollar) |
| Plan for restricted shares to employee (2018-1) Plan for restricted shares to employee (2019-1) " |
January 20, 2020 January 20, 2020 April 24, 2020 |
22.80 $ 22.80 18.20 |
- $ - - |
N/A N/A N/A |
3 years 3 years 3 years |
N/A N/A N/A |
N/A N/A N/A |
22.80 $ 22.80 18.20 |
- D. For the six-month periods ended June 30, 2024 and 2023, the subsidiary, Altek Medical Pte. Ltd.’s ( Altek Medical Holding (Cayman) Co., Ltd. relocated to Singapore and changed its name to Altek Medical Pte. Ltd.). Share-based payment arrangements were as follows:
| Type of arrangement | Grantdate | Quantity granted (share in thousands) |
Contract period |
Vesting conditions |
|---|---|---|---|---|
| Plan for restricted shares to employee Plan for restricted shares to employee Plan for restricted shares to employee |
November 2, 2021 Octorber 2, 2023 May 3, 2024 |
3,166 2,000 6,500 |
3 years 3 years 3 years |
Note Note Note |
Note: Employees have to pay to acquire those shares. The vesting condition is 1 to 3 years’ services or become vested under certain conditions.
The share-based payment transaction used the Black-Scholes option valuation model to estimate the fair value of the option. For the period from January 1 to June 30, 2024, the weighted average fair value of the Plan for restricted shares to employee granted was $0.1(in US dollars).
E. Expenses incurred on share-based payment transactions are shown below:
| Equity-settled Equity-settled |
Three-month period ended June 30,2024 15,102 $ Six-month period ended June 30,2024 15,102 $ |
Three-month period ended June 30,2023 |
|---|---|---|
| - $ |
||
| Six-month period ended June 30,2023 |
||
| 285 $ |
~28~
(17) Provisions
| Provisions | |||
|---|---|---|---|
| At January 1, 2024 Additional provisions Reversed during the period Exchange differences At June 30, 2024 Current Non-current |
$ ( $ June 30,2024 December31,2023 74,099 $ 67,256 $ 124,032 $ 130,998 $ |
Warranty 2024 198,254 7,800 8,107) 184 198,131 June 30,2023 58,885 $ 135,009 $ |
|
The Group provides warranties on digital image technology application products sold. Provision for warranties is estimated based on historical warranty data of digital image technology application products.
(18) Share capital
As of June 30, 2024, the Company’s authorised capital was $5,000,000, consisting of 500,000 thousand shares of ordinary stock, and the paid-in capital was $2,788,000 with a par value of $10 (in NT dollars) per share.
A. Movements in the number of the Company’s ordinary shares outstanding are as follows (share in thousands):
| At January 1 Retired restricted shares to employees that did not meet the vesting conditions At June 30 |
2024 276,710 - ( 276,710 |
2023 276,728 18) 276,710 |
|---|---|---|
B. Treasury shares
(a) Reason for share reacquisition and the number of the Company’s treasury shares are as follows :
| follows : | ||||
|---|---|---|---|---|
| Name of company holdingthe shares |
Reason for reacquisition | Number of shares (share in thousands) Carrying amount 2,090 38,101 $ June 30,2024 Number of shares (share in thousands) Carryingamount 2,090 38,101 $ December31,2023 |
June 30,2024 | |
| Carrying amount | ||||
| The Company Name of company holdingthe shares |
To be reissued to employees Reason for reacquisition |
38,101 $ |
||
| 31,2023 | ||||
| Carryingamount | ||||
| The Company | To be reissued to employees | 38,101 $ |
~29~
June 30, 2023
| Name of company holdingthe shares |
Reason for reacquisition | Number of shares (share in thousands) 2,090 |
Carryingamount |
|---|---|---|---|
| The Company | To be reissued to employees | 38,101 $ |
-
(b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.
-
(c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.
(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within five years from the reacquisition date and shares not reissued within the five-year period are to be retired.
(19) Capital surplus
Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new shares or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.
| reserve is insufficient. | |||
|---|---|---|---|
| At January 1 Changes in ownership interests in subsidiaries At June 30 At January 1 Employee restricted shares vested Reired restricted shares to employees that did not meet the vesting conditions At June 30 |
2024 | ||
| Sharepremium 1,925,458 $ - 1,925,458 $ |
Changes in ownership interests in subsidiaries Treasuryshares - $ 120,936 $ 6,780 - 6,780 $ 120,936 $ 2023 |
||
| Sharepremium 1,914,073 $ 11,385 - 1,925,458 $ |
Treasuryshares 120,936 $ - - 120,936 $ |
~30~
(20) Retained earnings
-
A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the relevant regulations. The remaining amount plus the unappropriated earnings of prior years are distributed in cash, based on the resolution by the Board of Directors. In the case of new shares, the distribution shall be proposed by the Board of Directors and resolved at the shareholders’ meeting.
-
Dividends and bonus, in the form of cash, could be resolved by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors and reported at the shareholders’ meeting.
-
B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy, cash dividends shall account for at least 20% of the total dividends distributed.
-
C. Except for covering accumulated deficit or issuing new shares or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of shares or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.
-
D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.
-
(b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Order No. Financial-Supervisory-Securities-Corporate1010012865, dated April 6, 2012, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.
~31~
E. The appropriation of 2023 and 2022 earnings had been resolved at the shareholders’ meeting on June 13, 2024 and June 21, 2023. Details are summarised below:
| Legal reserve (Reversal of) special reserve Cash dividends |
Dividends per share Dividends per share Amount (inNTdollars) Amount (inNTdollars) 27,926 $ 43,676 $ 108,904 259,420) ( 193,697 0.7 $ 276,728 1.0 $ 330,527 $ 60,984 $ 2023 2022 |
2022 | 2022 |
|---|---|---|---|
| Amount 27,926 $ 108,904 193,697 330,527 $ |
Dividends per share (inNTdollars) |
||
| 1.0 $ |
The appropriation of 2023 and 2022 earnings were the same as that proposed by the Board of Directors on March 11, 2024 and March 10, 2023, respectively.
(21) Other equity items
| Unrealised Foreign currency losses on translation valuation Total At January 1 445,272) ($ 179,044) ($ 624,316) ($ Valuation adjustment - 4,400) ( 4,400) ( Currency translation differences: -Group 399,882 - 399,882 At June 30 45,390) ($ 183,444) ($ 228,834) ($ 2024 Unrealised Foreign currency losses on Unearned translation valuation compensation Total At January 1 367,270) ($ 148,141) ($ 696) ($ 516,107) ($ Valuation adjustment - 1,658 - 1,658 Currency translation differences: -Group 66,552) ( - - 66,552) ( Retirement of restricted shares to employees - - 411 411 Share-based payment transactions - - 285 285 At June 30 433,822) ($ 146,483) ($ - $ 580,305) ($ 2023 |
2024 | Total 624,316) 4,400) 399,882 228,834) |
||
|---|---|---|---|---|
| Total |
~32~
(22) Operating revenue
| Operating revenue | ||
|---|---|---|
| Revenue from contracts with customers Revenue from contracts with customers |
Three-month period ended June 30,2024 1,704,446 $ Six-month period ended June 30,2024 3,304,288 $ |
Three-month period ended June 30,2023 |
| 2,208,835 $ |
||
| Six-month period ended June 30,2023 |
||
| 4,462,412 $ |
A. Disaggregation of revenue from contracts with customers
The Group derives revenue from the transfer of goods and services over time and at a point in time in the following major geographical regions:
| Three-month period ended June 30,2024 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total Three-month period ended June 30,2023 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total Six-month period ended June 30,2024 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total |
Asia 789,720 $ 769,594 $ 20,126 789,720 $ Asia 1,078,547 $ 1,007,718 $ 70,829 1,078,547 $ Asia 1,397,132 $ 1,325,576 $ 71,556 1,397,132 $ |
Europe 309,806 $ 274,369 $ 35,437 309,806 $ Europe 447,179 $ 436,763 $ 10,416 447,179 $ Europe 779,026 $ 739,521 $ 39,505 779,026 $ |
America 604,499 $ 491,428 $ 113,071 604,499 $ America 683,109 $ 664,289 $ 18,820 683,109 $ America 1,127,546 $ 943,210 $ 184,336 1,127,546 $ |
Taiwan 421 $ 420 $ 1 421 $ Taiwan - $ - $ - - $ Taiwan 584 $ 420 $ 164 584 $ |
Total |
|---|---|---|---|---|---|
| 1,704,446 $ |
|||||
| 1,535,811 $ 168,635 |
|||||
| 1,704,446 $ |
|||||
| Total | |||||
| 2,208,835 $ |
|||||
| 2,108,770 $ 100,065 |
|||||
| 2,208,835 $ |
|||||
| Total | |||||
| 3,304,288 $ |
|||||
| 3,008,727 $ 295,561 |
|||||
| 3,304,288 $ |
~33~
| Six-month period ended June 30,2023 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total |
Asia 2,194,581 $ 2,087,494 $ 107,087 2,194,581 $ |
Europe 823,790 $ 765,005 $ 58,785 823,790 $ |
America 1,438,959 $ 1,366,959 $ 72,000 1,438,959 $ |
Taiwan 5,082 $ 3,511 $ 1,571 5,082 $ |
Total |
|---|---|---|---|---|---|
| 4,462,412 $ |
|||||
| 4,222,969 $ 239,443 |
|||||
| 4,462,412 $ |
B. Contract liabilities
The Group has recognised the following revenue-related contract liabilities:
| Contract liabilities |
June 30,2024 December31,2023 191,253 $ 351,051 $ |
June 30,2023 455,805 $ |
January1,2023 |
|---|---|---|---|
| 439,481 $ |
C. Revenue recognised that was included in the contract liabilities at the beginning of the period
| Interest income Revenue recognised that was included in the contract liabilities at the beginning of the period Revenue recognised that was included in the contract liabilities at the beginning of the period Interest income from bank deposits Interest income from financial assets measured at amortised cost Other interest income |
Three-month period ended June 30,2024 71,332 $ Six-month period ended June 30,2024 223,621 $ Three-month period ended June 30,2024 20,269 $ 36,043 - 56,312 $ |
Three-month period ended June 30,2023 |
|---|---|---|
| 74,961 $ |
||
| Six-month period ended June 30,2023 |
||
| 154,451 $ |
||
| Three-month period ended June 30,2023 |
||
| 45,200 $ 9,645 13 |
||
| 54,858 $ |
(23) Interest income
~34~
| (24) (25) |
Other income Other gains and losses Six-month Six-month period ended period ended June 30,2024 June 30,2023 Interest income from bank deposits 46,305 $ 73,903 $ Interest income from financial assets measured at amortised cost 58,141 17,623 Other interest income 1 27 104,447 $ 91,553 $ Three-month Three-month period ended period ended June 30,2024 June 30,2023 Rent income 18,549 $ 14,172 $ Other income - others 5,471 11,480 24,020 $ 25,652 $ Six-month Six-month period ended period ended June 30,2024 June 30,2023 Rent income 36,890 $ 29,088 $ Other income - others 12,930 19,013 49,820 $ 48,101 $ Three-month Three-month period ended period ended June 30,2024 June 30,2023 Gain on disposal of property, plant and equipment 17 $ - $ Net currency exchange (losses) gains 885) ( 4,167 Net loss on financial assets at fair value through profit or loss 519) ( 12,691) ( Other expenses 5,371) ( 167) ( 6,758) ($ 8,691) ($ |
|---|---|
~35~
| Six-month | Six-month | |||||
|---|---|---|---|---|---|---|
| period ended | period ended | |||||
| June 30,2024 | June 30,2023 | |||||
| Gain on disposal of property, plant and | $ | 17 |
$ | 11 |
||
| equipment | ||||||
| Net currency exchange gains (losses) | 13,217 | ( | 2,039) |
|||
| Net loss on financial assets at fair | ||||||
| value through profit or loss | ( | 549) |
( | 6,860) |
||
| Other expenses | ( | 10,930) |
( | 363) |
||
| $ | 1,755 | ($ | 9,251) | |||
| Finance costs | ||||||
| Three-month | Three-month | |||||
| period ended | period ended | |||||
| June 30,2024 | June 30,2023 | |||||
| Interest expense : | ||||||
| Bank loan | $ | 12,582 |
$ | 15,653 |
||
| Lease liabilities | 617 | 567 | ||||
| Other | - | 459 | ||||
| $ | 13,199 | $ | 16,679 | |||
| Six-month | Six-month | |||||
| period ended | period ended | |||||
| June 30,2024 | June 30,2023 | |||||
| Interest expense : | ||||||
| Bank loan | $ | 27,368 |
$ | 29,778 |
||
| Lease liabilities | 1,246 | 907 | ||||
| Other | - | 2,280 | ||||
| $ | 28,614 | $ | 32,965 | |||
| Expenses by nature | ||||||
| Three-month | Three-month | |||||
| period ended | period ended | |||||
| June 30,2024 | June 30,2023 | |||||
| Employee benefit expenses | $ | 404,225 |
$ | 373,086 |
||
| Depreciation charges on property, plant and | ||||||
| equipment | 30,559 | 37,999 | ||||
| Depreciation charges on right-of-use assets | 5,368 | 5,653 | ||||
| Depreciation charges on investment property | 6,520 | 6,341 | ||||
| Amortisation charges on intangible assets | 10,992 | 39,636 |
(26) Finance costs
(27) Expenses by nature
~36~
| Employee benefit expenses Employee benefit expenses Depreciation charges on property, plant and equipment Depreciation charges on right-of-use assets Depreciation charges on investment property Amortisation charges on intangible assets Wages and salaries Labour and health insurance fees Pension costs Other personnel expenses Wages and salaries Labour and health insurance fees Pension costs Other personnel expenses |
Six-month period ended June 30, 2024 758,821 $ 60,010 10,636 12,905 20,095 Three-month period ended June 30,2024 363,543 $ 16,818 14,252 9,612 404,225 $ Six-month period ended June 30,2024 679,728 $ 31,866 28,401 18,826 758,821 $ |
Six-month period ended June 30, 2023 |
|---|---|---|
| 742,704 $ 79,337 10,204 12,747 78,602 Three-month period ended June 30,2023 |
||
| 333,017 $ 15,385 14,104 10,580 |
||
| 373,086 $ |
||
| Six-month period ended June 30,2023 |
||
| 658,930 $ 33,116 29,130 21,528 |
||
| 742,704 $ |
(28) Employee benefit expenses
- A. According to the Articles of Incorporation of the Company, employees’ compensation and directors’ remuneration shall be calculated based on current year’s earnings, which should first be used to cover accumulated deficit, if any, 10% to 20% for employees’ compensation and no more than 5% for directors’ remuneration. Employees’ compensation can be distributed in the form of shares or in cash. Employees of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned shares or cash.
Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, distribute employees’ compensation and directors’ remuneration and report such distribution to the shareholders’ meeting.
- B. For the three-month and six-month periods ended June 30, 2024 and 2023, employees’ compensation was accrued at $15,319, $21,962, $31,457 and $35,827, respectively; directors’ remuneration was accrued at $5,107, $7,320, $10,486 and $11,942, respectively. The aforementioned amounts were calculated based on the Articles of Incorporation of the Company and recognised in salary expenses.
~37~
Employees’ compensation and directors’ remuneration for 2023 amounting to $76,140 and $25,380, respectively, as resolved at the meeting of Board of Directors were in agreement with those amounts recognised in the 2023 financial statements.
Information about employees’ compensation and directors’ remuneration of the Company as resolved at the meeting of Board of Directors will be posted in the “Market Observation Post System” at the website of the Taiwan Stock Exchange.
(29) Income tax
-
A. Income tax expense
-
(a) Components of income tax expense:
| Current tax: Current tax on profit for the period Charge on unappropriated retained earnings Prior year income tax under (over) estimation Total current tax Deferred tax: Origination and reversal of temporary differences Income tax expense Current tax: Current tax on profit for the period Charge on unappropriated retained earnings Tax paid outside of the territory of the Republic of China Prior year income tax over estimation ( Total current tax Deferred tax: Origination and reversal of temporary differences ( Income tax expense |
Three-month period ended June 30,2024 29,274 $ 1,047 2,556 ( 32,877 13,731 ( 46,608 $ Six-month period ended June 30,2024 92,534 $ 11,358 - 5,754) ( 98,138 4,883) ( 93,255 $ |
Three-month period ended June 30,2023 66,219 $ 21,902 1,901) 86,220 33,425) 52,795 $ Six-month period ended June 30,2023 104,785 $ 21,902 805 1,901) 125,591 41,968) 83,623 $ |
|---|---|---|
~38~
(b) The income tax charged to other comprehensive income is as follows:
| Translation differences of foreign operations Translation differences of foreign operations |
Three-month Three-month period ended period ended June 30,2024 June 30,2023 21,763 $ 16,046) ($ Six-month Six-month period ended period ended June 30,2024 June 30,2023 99,970 $ 16,638) ($ |
|---|---|
B. The Company’s income tax returns through 2021 have been assessed and approved by the Tax Authority.
(30) Earnings per share
| Earnings per share | |||
|---|---|---|---|
| Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Employees’ compensation Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares |
Three-monthperiod ended June 30,2024 | ||
| Amount after tax 77,380 $ 77,380 $ - 77,380 $ |
Weighted average number of ordinary shares outstanding (share in thousands) 276,710 802 277,512 |
Earnings per share (in dollars) |
|
| 0.28 $ |
|||
| 0.28 $ |
~39~
| Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Employees’ compensation Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Employees’ compensation Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares |
Three-monthperiod ended June 30,2023 | Three-monthperiod ended June 30,2023 | Three-monthperiod ended June 30,2023 |
|---|---|---|---|
| Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) 91,969 $ 276,705 0.33 $ 91,969 $ - 5 - 1,082 91,969 $ 277,792 0.33 $ Six-monthperiod ended June 30,2024 |
Earnings per share (in dollars) |
||
| 0.33 $ |
|||
| 0.33 $ |
|||
| Amount after tax 153,786 $ 153,786 $ - 153,786 $ |
Weighted average number of ordinary shares outstanding (share in thousands) 276,710 1,705 278,415 |
Earnings per share (in dollars) |
|
| 0.56 $ |
|||
| 0.55 $ |
~40~
| (31) (32) |
Transactions with non-controlling interest Altek International Investment Co., Ltd. a subsidiary of the Group, repurchased shares from shareholders of non-controlling interests in June 2023, thus increased the Group's shareholding ratio by 28.57%. The effect of changes in interests on the equity attributable to owners of the parent is shown below: Supplemental cash flow information A. Investing activities with partial cash payments: Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) Basic earnings per share Profit attributable to ordinary shareholders of the parent 158,325 $ 276,414 0.57 $ Diluted earnings per share Profit attributable to ordinary shareholders of the parent 158,325 $ Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees - 302 Employees’ compensation - 2,055 Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares 158,325 $ 278,771 0.57 $ Six-monthperiod ended June 30,2023 Six-month Six-month period ended period ended June 30,2024 June 30,2023 Consideration paid to non-controlling interests - $ 73,680) ($ Decrease in the carrying amount of non-controlling interests - 5,674 Capital surplus - $ 68,006) ($ Six-month Six-month period ended period ended June 30,2024 June 30,2023 Acquisition of property, plant, and equipment 58,637 $ 46,222 $ Add: Payable on equipment at beginning of period 329 957 Less: Payable on equipment at end of period 17,364) ( 2,844) ( Cash paid 41,602 $ 44,335 $ |
|---|---|
~41~
| Acquisition of intangible assets Add: Payables at beginning of period Less: Payables at end of period ( Cash paid |
Six-month period ended June 30,2024 4,983 $ 42,618 43,772) ( 3,829 $ |
Six-month period ended June 30,2023 36,725 $ 10,686 44,251) 3,160 $ |
|---|---|---|
B. Financing activities with no cash flow effects:
Declaration of cash dividends
| Six-month period ended June 30,2024 193,697 $ |
Six-month period ended June 30,2023 |
|---|---|
| 276,728 $ |
(33) Changes in liabilities from financing activities
| January 1, 2024 Changes in cash flow from financing activities Interest expenses Declaration of cash dividends Other non-cash items changes Impact of changes in foreign exchange rate June 30, 2024 |
Short-term borrowings |
Long-term borrowings (including current portion) |
Guarantee deposits received |
Lease liabilities |
Dividends payable |
Total | |||
|---|---|---|---|---|---|---|---|---|---|
| 2,234,704 $ 622,609) ( - - - 4,949 1,617,044 $ |
900,000 $ - - - - - 900,000 $ |
36,431 $ 45 - - - 1,504 37,980 $ |
132,175 $ 11,029) ( 1,246 - 35 1,385 123,812 $ |
- $ - - 193,697 - - 193,697 $ |
3,303,310 $ 633,593) ( 1,246 193,697 35 7,838 2,872,533 $ |
~42~
| January 1, 2023 Changes in cash flow from financing activities Interest expenses Declaration of cash dividends Other non-cash items changes Impact of changes in foreign exchange rate June 30, 2023 |
Short-term borrowings |
Short-term notes and billspayable |
Long-term borrowings (including current portion) |
Guarantee deposits received |
Lease liabilities |
Dividends payable |
Total | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,213,000 $ 33,261 - - - 2,070) ( 2,244,191 $ |
399,669 $ 302,015) ( 2,280 - - - 99,934 $ |
500,000 $ 400,000 - - - - 900,000 $ |
36,422 $ 9) ( - - - 676) ( 35,737 $ |
111,366 $ 10,051) ( 907 - 37,682 216) ( 139,688 $ |
- $ - - 276,728 - - 276,728 $ |
3,260,457 $ 121,186 3,187 276,728 37,682 2,962) ( 3,696,278 $ |
7. RELATED PARTY TRANSACTIONS
(1) Names of related parties and relationship: None.
(2) Significant transactions and balances with related parties: No significant related party transactions. (3) Key management compensation
| Key management compensation | ||
|---|---|---|
| Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total |
Three-month period ended June 30,2024 51,368 $ 122 - 51,490 $ Six-month period ended June 30,2024 105,150 $ 283 - 105,433 $ |
Three-month period ended June 30,2023 |
| 12,578 $ 241 - |
||
| 12,819 $ |
||
| Six-month period ended June 30,2023 |
||
| 38,246 $ 483 78 |
||
| 38,807 $ |
~43~
8. PLEDGED ASSETS
The Group’s assets pledged as collateral are as follows:
| Pledgedasset Purpose Land and buildings Medium and long-term loans Investment property Medium and long-term loans |
June 30,2024 December31,2023 209,489 $ 210,574 $ 727,090 730,387 936,579 $ 940,961 $ Bookvalue |
|
|---|---|---|
| June 30,2023 211,659 $ 733,683 945,342 $ |
9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT
COMMITMENTS
None.
10. SIGNIFICANT DISASTER LOSS
None.
11. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD
None.
12. OTHERS
(1) Capital management
The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.
(2) Financial instruments
A. Financial instruments by category
| Financial instruments by category | ||
|---|---|---|
| Financial assets Financial assets at fair value through profit or loss Financial assets at fair value through other comprehensive income Financial assets at amortised cost Cash and cash equivalents Financial assets at amortised cost Notes receivable Accounts receivable Other accounts receivable Guarantee deposit paid |
June 30,2024 December31,2023 125,403 $ 124,007 $ 38,361 $ 38,461 $ 3,772,714 $ 5,798,794 $ 3,930,522 1,473,972 36,001 28,796 1,104,031 1,741,007 109,452 68,885 34,345 35,953 8,987,065 $ 9,147,407 $ |
June 30,2023 |
| 107,600 $ |
||
| 71,545 $ |
||
| 6,062,081 $ 1,335,963 46,726 1,624,152 58,081 39,158 |
||
| 9,166,161 $ |
~44~
June 30, 2024 December 31, 2023 June 30, 2023
| June 30,2024 |
December31,2023 | June 30,2023 | |
|---|---|---|---|
| Financial liabilities Financial liabilities at amortised cost Short-term borrowings Short-term notes and bills payable Accounts payable Other payables Long-term borrowings (including current portion) Guarantee deposits received Lease liabilities |
1,617,044 $ - 1,044,253 999,578 900,000 37,980 4,598,855 $ 123,812 $ |
2,234,704 $ - 1,240,588 917,502 900,000 36,431 5,329,225 $ 132,175 $ |
2,244,191 $ 99,934 1,470,145 1,015,253 900,000 35,737 |
| 5,765,260 $ |
|||
| 139,688 $ |
-
B. Financial risk management policies
-
(a) The Group’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. The Group’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Group’s financial position and financial performance.
-
(b) Risk management is carried out by a Group treasury department under policies approved by the Board of Directors. Group treasury identifies, evaluates and hedges financial risks in close co-operation with the Group’s operating units. The Board provides written principles for overall risk management, as well as written policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.
-
C. Significant financial risks and degrees of financial risks
-
(a) Market risk
Foreign exchange risk
-
i. The Group operates internationally and is exposed to exchange rate risk arising from the transactions of the Company and its subsidiaries used in various functional currency, primarily with respect to the USD and RMB. Exchange rate risk arises from future commercial transactions and recognised assets and liabilities.
-
ii. Exchange rate risk arises when future commercial transactions, recognised assets or liabilities are denominated in a foreign currency that is not the entity's functional currency. The Group's management has established a policy to its subsidiaries in the group to hedge its overall exchange rate risk through the Group’s finance department.
~45~
-
iii. The Group has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Group’s foreign operations is managed primarily through transactions denominated in the relevant foreign currencies.
-
iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:
| Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 36,862 USD USD:RMB 32,798 USD Financial liabilities Monetary items USD:NTD 33,109 USD USD:RMB 27,608 USD Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 52,681 USD USD:RMB 39,257 USD Financial liabilities Monetary items USD:NTD 47,198 USD USD:RMB 34,250 USD |
June 30, | 2024 | 2024 | ||
|---|---|---|---|---|---|
| Effect on Effect on Other Exchange Book Value Extent of Profit or Comprehensive Rate (NTD) Variation (Loss) Income(Loss) 32.450 1,196,172 $ 1% 11,962 $ - $ 7.1268 1,064,295 1% 10,643 - 32.450 1,074,387 $ 1% 10,744) ($ - $ 7.1268 895,880 1% 8,959) ( - SensitivityAnalysis December31,2023 |
SensitivityAnalysis | ||||
| Effect on Other Comprehensive Income(Loss) |
|||||
| - $ - - $ - |
|||||
| Exchange Rate 30.705 7.0827 30.705 7.0827 |
Book Value (NTD) 1,617,570 $ 1,205,386 1,449,215 $ 1,051,646 |
SensitivityAnalysis | |||
| Effect on Extent of Profit or Variation (Loss) 1% 16,176 $ 1% 12,054 1% 14,492) ($ 1% 10,516) ( |
Effect on Other Comprehensive Income(Loss) |
||||
| - $ - - $ - |
|||||
~46~
June 30, 2023
| June 30, | 2023 | 2023 | ||
|---|---|---|---|---|
| Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 61,670 USD USD:RMB 43,898 USD Financial liabilities Monetary items USD:NTD 54,308 USD USD:RMB 39,243 USD |
Exchange Rate 31.140 7.2258 31.140 7.2258 |
Book Value (NTD) 1,920,404 $ 1,366,984 1,691,151 $ 1,222,027 |
SensitivityAnalysis | |
| Effect on Extent of Profit or Variation (Loss) 1% 19,204 $ 1% 13,670 1% 16,912) ($ 1% 12,220) ( |
Effect on Other Comprehensive Income(Loss) |
|||
| - $ - - $ - |
||||
- v. Total exchange gain (loss) including realised and unrealised arising from significant foreign exchange variation on the monetary items held by the Group for the three-month and six-month periods ended June 30, 2024 and 2023, amounted to ($885), $4,167, $13,217 and ($2,039), respectively.
Price risk
-
i. The Group’s investments in equity securities, which are exposed to price risk, are the held financial assets at fair value through profit or loss and financial assets at fair value through other comprehensive income.
-
ii. The Group’s investments in equity securities comprise shares issued by the domestic companies. The prices of equity securities would change due to the change of the future value of investee companies. If the prices of these equity securities had increased/decreased by 10% with all other variables held constant, post-tax profit for the and six-month periods ended June 30, 2024 and 2023 would have increased/decreased by $8,924 and $7,646, respectively, as a result of gains/losses on equity securities classified as at fair value through profit or loss. Other components of equity would have increased/decreased by $3,836 and $7,155, respectively, as a result of price change on equity investments at fair value through other comprehensive income.
Cash flow and fair value interest rate risk
The Group’s main interest rate risk arises from long-term and short-term borrowings. If the borrowing interest rate had increased/decreased by one yard with all other variables held constant, profit before tax for the six-month periods ended June 30, 2024 and 2023 would have increased/decreased by $3,146 and $3,930, respectively. The main factor is that changes in interest expense result in floating-rate borrowings.
~47~
(b) Credit risk
-
i. Credit risk refers to the risk of financial loss to the Group arising from default by customers or counterparties of financial instruments on the contract obligations. The main factor is that counterparties could not repay in full the accounts receivable based on the agreed terms.
-
ii. The Group manages their credit risk taking into consideration the entire Group’s concern. According to the Group’s credit policy, each local entity in the Group is responsible for managing and analysing the credit risk for each of their new customers before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings in accordance with limits set by the Board of Directors. The utilisation of credit limits is regularly monitored.
-
iii. The Group measured internal operating procedures, past experience of trading customers, and actual transaction status. If the contract payments were past due over 90 days based on the terms, there has been a significant increase in credit risk on that instrument since initial recognition. If the contract payments were past due over 360 days based on the term, the default has occurred.
-
iv. The following indicators are used to determine whether the credit impairment of debt instruments has occurred:
-
(i) It becomes probable that the issuer will enter bankruptcy or other financial reorganisation due to their financial difficulties;
-
(ii) The disappearance of an active market for that financial asset because of financial difficulties;
-
(iii) Default or delinquency in interest or principal repayments;
-
(iv) Adverse changes in national or regional economic conditions that are expected to cause a default.
-
v. The Group classifies customers’ accounts receivable, notes receivable and contract assets in accordance with customer types. The Group applies the simplified approach using loss provision matrix to estimate expected credit loss under the provision matrix basis.
-
vi. The Group wrote-off the financial assets, which cannot be reasonably expected to be recovered, after initiating recourse procedures. However, the Group will continue executing the recourse procedures to secure their rights.
~48~
vii. The Group used the forecastability to adjust historical and timely information to access the default possibility of contract assets, notes receivable and accounts receivable. As of June 30, 2024, December 31, 2023, and June 30, 2023, the provision matrix is as follows:
| June 30,2024 Expected loss rate Total book value Loss allowance December 31,2023 Expected loss rate Total book value Loss allowance June 30,2023 Expected loss rate Total book value Loss allowance |
Up to 90 days past due |
91 to180 days past due |
181 to 360 dayspast due |
Over 361 days |
Total |
|---|---|---|---|---|---|
| 0.02% ~ 0.03% 1,139,620 $ 238 $ Up to 90 days past due |
15%~20% 807 $ 157 $ 91 to180 days past due |
30%~40% - $ - $ 181 to 360 dayspast due |
100% - $ - $ Over 361 days |
1,140,427 $ 395 $ Total |
|
| 0.04% 1,770,379 $ 699 $ Up to 90 days past due |
15%~20% 208 $ 208 $ 91 to180 days past due |
30%~40% 682 $ 559 $ 181 to 360 dayspast due |
100% - $ - $ Over 361 days |
1,771,269 $ 1,466 $ Total |
|
| 0.03%~0.04% 1,671,365 $ 653 $ |
15%~20% 207 $ 41 $ |
30%~40% - $ - $ |
100% - $ - $ |
1,671,572 $ 694 $ |
viii. Movements in relation to the Group applying the simplified approach to provide loss allowance for contract assets and accounts receivable are as follows:
| 2024 | 2024 | 2024 | |||||
|---|---|---|---|---|---|---|---|
| Contract assets | Accounts | receivable | |||||
| At January 1 | $ | - |
$ | 1,466 |
|||
| Reversal of impairment loss | - | ( | 1,104) |
||||
| Effect of foreign exchange | - | 33 | |||||
| At June 30 | $ | - | $ | 395 | |||
| 2023 | |||||||
| Contract assets | Accounts | receivable | |||||
| At January 1 | $ | 4 |
$ | 454 |
|||
| (Reversal of) impairment loss | ( | 4) |
242 | ||||
| Effect of foreign exchange | - | ( | 2) |
||||
| At June 30 | $ | - | $ | 694 |
ix. Movements in loss allowance for investments in debt instruments carried at amortised cost are as follows:
~49~
| Financial assets at amortised cost Group 1 Group 2 Financial assets at amortised cost Group 1 Financial assets at amortised cost Group 1 |
June 30,2024 | June 30,2024 | June 30,2024 | |||||
|---|---|---|---|---|---|---|---|---|
| 12 months | Lifetime | Total | ||||||
| Significant increase in credit risk |
Impairment of credit |
|||||||
| 3,647,009 $ 283,513 3,930,522 $ |
- $ - - $ 31,2023 |
3,647,009 $ 283,513 3,930,522 $ |
||||||
| 12 months | Lifetime | Total | ||||||
| Significant increase in credit risk |
Impairment of credit |
|||||||
| 1,473,972 $ |
1,473,972 $ |
|||||||
| 12 months | Lifetime | Total | ||||||
| Significant increase in credit risk |
Impairment of credit |
|||||||
| 1,335,963 $ |
- $ |
- $ |
1,335,963 $ |
Group 1: Time deposits with an original maturity of more than three months from financial institutions with good credit quality.
Group 2: Standard Poor’s or Moody’s rating of A-level.
(c) Liquidity risk
- i. Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group treasury. Group treasury monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Group’s debt financing plans, and compliance with internal balance sheet ratio targets.
~50~
- ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Group treasury. Group treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient headroom as determined by the above-mentioned forecasts.
iii.The Group has the following undrawn borrowing facilities:
| Fixed rate: Expiring within one year Expiring over one year |
June 30,2024 5,717,811 $ 100,000 5,817,811 $ |
December 31,2023 4,604,940 $ 100,000 4,704,940 $ |
June 30,2023 |
|---|---|---|---|
| 4,192,688 $ 100,000 |
|||
| 4,292,688 $ |
- iv.The table below analyses the Group’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.
| June 30, 2024 Non-derivative financial liabilities: Short-term borrowings Accounts payable Other payables Lease liabilities Guarantee deposits received Long-term borrowings (including current portion) December 31, 2023 Non-derivative financial liabilities: Short-term borrowings Accounts payable Other payables Lease liabilities Guarantee deposits received Long-term borrowings (including current portion) |
Lessthan 1year 1,623,105 $ 1,044,253 999,578 19,192 - 917,388 Lessthan 1year 2,242,356 $ 1,240,588 917,502 20,916 - - |
1 to 3 years - $ - - 21,945 37,980 - 1 to 3 years - $ - - 24,483 36,431 924,967 |
Over3 years |
|---|---|---|---|
| - $ - - 100,140 - - Over3 years - $ - - 105,411 - - |
~51~
| June 30, 2023 Non-derivative financial liabilities: Short-term borrowings Short-term notes and bills payable Accounts payable Other payables Lease liabilities Guarantee deposits received Long-term borrowings (including current portion) |
Lessthan 1year 2,251,624 $ 99,934 1,470,145 1,015,253 22,820 - - |
1 to 3 years - $ - - - 29,557 35,737 933,788 |
Over3 years |
|---|---|---|---|
| - $ - - - 107,234 - - |
(3) Fair value estimation
-
A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:
-
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
-
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
-
Level 3: Unobservable inputs for the asset or liability. The fair value of the Group’s investment in equity investment without active market.
-
B. Fair value information of investment property at cost is provided in Note 6(9).
-
C. Financial instruments were not measured at fair value, including the carrying amounts of cash and cash equivalents, financial assets at amortised cost, notes receivable, accounts receivable, other receivables, deposits paid, short-term borrowings, short-term notes and bills payable, accounts payable, other payables, long-term borrowings (including current portion), deposit received and lease liabilities are approximate to their fair values.
~52~
-
D. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities are as follows:
-
(a) The related information of natures of the assets is as follows:
| June 30, 2024 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Hybrid instruments Financial assets at fair value through other comprehensive income Unlisted stocks December 31, 2023 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Hybrid instruments Financial assets at fair value through other comprehensive income Unlisted stocks |
Level 1 - $ - - - $ Level 1 - $ - - - $ |
Level 2 - $ - - - $ Level 2 - $ - - - $ |
Level3 89,240 $ 36,163 38,361 163,764 $ Level3 89,789 $ 34,218 38,461 162,468 $ |
Total |
|---|---|---|---|---|
| 89,240 $ 36,163 38,361 |
||||
| 163,764 $ |
||||
| Total | ||||
| 89,789 $ 34,218 38,461 |
||||
| 162,468 $ |
~53~
| June 30, 2023 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Hybrid instruments Financial assets at fair value through other comprehensive income Unlisted stocks |
Level 1 - $ - - - $ |
Level 2 - $ - - - $ |
Level3 76,460 $ 31,140 71,545 179,145 $ |
Total |
|---|---|---|---|---|
| 76,460 $ 31,140 71,545 |
||||
| 179,145 $ |
-
(b) The methods and assumptions the Group used to measure fair value are as follows:
- i. Except for financial instruments with active markets, the fair value of other financial instruments is measured by using valuation techniques. The fair value of financial instruments measured by using valuation techniques can be referred to current fair value of instruments with similar terms and characteristics in substance, discounted cash flow method or other valuation methods, including calculated by applying model using market information available at the consolidated balance sheet date.
-
ii. The output of valuation model is an estimated value and the valuation technique may not be able to capture all relevant factors of the Group’s financial and non-financial instruments. Therefore, the estimated value derived using valuation model is adjusted accordingly with additional inputs.
-
E. For the six-month periods ended June 30, 2024 and 2023, there was no transfer between Level 1 and Level 2.
-
F. The following table is the movement of Level 3 for the six-month periods ended June 30, 2024 and 2023:
| and 2023: | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | |||||
| At January 1 | $ | 162,468 |
$ | 158,539 |
||
| Purchases in the period | - | 30,325 | ||||
| Losses recognised in profit or loss | ( | 549) |
( | 7,141) |
||
| Gains recognised in other comprehensive (loss) | ||||||
| income | ( | 4,400) |
1,658 | |||
| Proceeds from capital reduction in the period | ( | 1,607) |
( | 2,323) |
||
| Effect of exchange rate changes | 7,852 | ( | 1,913) |
|||
| At June 30 | $ | 163,764 | $ | 179,145 |
- G. For the six-month periods ended June 30, 2024 and 2023, there was no transfer in or out from Level 3.
~54~
-
H. Accounting Department segment is in charge of valuation procedures for fair value measurements being categorised within Level 3, which is to verify independent fair value of financial instruments. Such assessment is to ensure the valuation results are reasonable by applying independent information to make results close to current market conditions, confirming the resource of information is independent, reliable and in line with other resources and represented as the exercisable price, and frequently calibrating valuation model, performing back-testing, updating inputs used to the valuation model and making any other necessary adjustments to the fair value.
-
I. The following is the qualitative information of significant unobservable inputs and sensitivity analysis of changes in significant unobservable inputs to valuation model used in Level 3 fair value measurement:
(Blank below)
~55~
| Financial assets at fair value through profit or loss Unlisted stocks Hybrid instrument -Convertible notes Financial assets at fair value through other comprehensive income Unlisted stocks Unlisted stocks |
Fair value at June 30, 2024 |
Valuation technique |
Significant unobservable input |
Relationship of inputs to fair value |
|---|---|---|---|---|
| $ 89,240 36,163 38,361 - |
Market comparable companies Binomial model Net asset value Discounted cash flow |
Price to earnings ratio multiple, price to book ratio multiple, discount for lack of marketability, control premium Discount rate Not applicable Long-term revenue growth rate, weighted average cost of capital, long- term pre-tax operating margin, discount for lack of marketability, discount for lack of control |
The higher the multiple and control premium, the higher the fair value The higher the discount rate, the lower the fair value Not applicable The higher the long-term revenue growth rate and the long-term pre-tax operating profit, the higher the fair value; the higher the weighted average cost of capital and minority equity discount, the lower the fair value |
~56~
| Financial assets at fair value through profit or loss Unlisted stocks Hybrid instrument -Convertible notes Financial assets at fair value through other comprehensive income Unlisted stocks Unlisted stocks |
Fair value at December 31,2023 |
Valuation technique |
Significant unobservableinput |
Relationship of inputs to fairvalue |
|---|---|---|---|---|
| $ 89,789 34,218 38,461 - |
Market comparable companies Binomial model Net asset value Discounted cash flow |
Price to earnings ratio multiple, price to book ratio multiple, discount for lack of marketability, control premium Discount rate Not applicable Long-term revenue growth rate, weighted average cost of capital, long- term pre-tax operating margin, discount for lack of marketability, discount for lack of control |
The higher the multiple and control premium, the higher the fair value The higher the discount rate, the lower the fair value Not applicable The higher the long-term revenue growth rate and the long-term pre-tax operating profit, the higher the fair value; the higher the weighted average cost of capital and minority equity discount, the lower the fair value |
~57~
| Financial assets at fair value through profit or loss Unlisted stocks Hybrid instrument -Convertible notes Financial assets at fair value through other comprehensive income Unlisted stocks Unlisted stocks |
Fair value at June 30, 2023 |
Valuation technique |
Significant unobservableinput |
Relationship of inputs to fairvalue |
|---|---|---|---|---|
| $ 76,460 31,140 34,655 36,890 |
Market comparable companies Binomial Mode Net asset value Discounted cash flow |
Price to earnings ratio multiple, price to book ratio multiple, discount for lack of marketability, control premium Discount rate Not applicable Long-term revenue growth rate, weighted average cost of capital, long- term pre-tax operating margin, discount for lack of marketability, discount for lack of control |
The higher the multiple and control premium, the higher the fair value The higher the discount rate, the lower the fair value Not applicable The higher the long-term revenue growth rate and the long-term pre-tax operating profit, the higher the fair value; the higher the weighted average cost of capital and minority equity discount, the lower the fair value |
~58~
13. SUPPLEMENTARY DISCLOSURES
(1) Significant transactions information
-
A. Loans to others: Please refer to table 1.
-
B. Provision of endorsements and guarantees to others: None.
-
C. Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures) : Please refer to table 2.
-
D. Acquisition or sale of the same security with the accumulated cost exceeding NT$300 million or 20% of the Company’s paid-in capital: None.
-
E. Acquisition of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
F. Disposal of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
G. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paidin capital or more: Please refer to table 3.
-
H. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 4.
-
I. Trading in derivative financial instruments undertaken during the reporting periods: None.
-
J. Significant inter-company transactions during the reporting period: Please refer to table 5.
(2) Information on investees
Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 6.
(3) Information on investments in Mainland China
-
A. The related information of investments in Mainland China: Please refer to table 7.
-
B. Significant transactions, either directly or indirectly through a third area, with investee companies in Mainland China: Please refer to table 3 ~ table 5.
(4) Major shareholders information
Please refer to table 8.
14. SEGMENT INFORMATION
(1) General information
The Group mainly operates in one segment. The Chief Operating Decision-Maker reviews the Group’s reporting to assess performance and allocate resources. The Group mainly has one single reportable segment.
(2) Measurement of segment information
The Group evaluates performance based on profit or loss by using sales revenue and operation profit measurements. The accounting policies of the Group's operating segments are the same as the significant accounting policies summarised in Note 4.
~59~
(3) Information about segment profit or loss, assets and liabilities
The Group has a single reportable segment. The revenue from external customers, the related gain or loss, and the assets correspond with the consolidated revenue, consolidated operating income, and consolidated assets.
(4) Reconciliation for segment income (loss)
The amounts provided to the Chief Operating Decision-Maker with respect to department assets, liabilities and profit are measured in a manner consistent with that of the financial statements.
(Blank below)
~60~
Table 1
Altek Corporation and subsidiaries Loans to other For the six-month period ended June 30, 2024
Expressed in thousands of NTD (Except as otherwise indicated)
| No. | Creditor | Borrower | General ledger account |
Is a related party |
Maximum outstanding balance during the six-month period ended June 30, 2024 |
Balance at June 30, 2024 |
Actual amount drawn down |
Interest rate |
Nature of loan |
Amount of transactions with the borrower |
Reason term financing |
Allowance for doubtful accounts |
Collateral | Collateral | Limit on loans granted to a single party (Note) |
Ceiling on total loans granted (Note) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | Value | |||||||||||||||
| 0 1 2 |
Altek Corporation Altek (Kunshan) Co., Ltd. Altek International Holding (BVI) Co., Ltd. |
Altek Semiconductor Corporation Altek Optical Technology (Kunshan) Co. , Ltd. Altek Medical Pte. Ltd. |
Other receivables- related party Other receivables- related party Other receivables- related party |
Yes Yes Yes |
250,000 $ 45,797 227,815 |
250,000 $ 45,532 227,150 |
- $ 45,532 64,900 |
2% 3% 0% |
Reason for short-term financing Reason for short-term financing Reason for short-term financing |
- $ - - |
Operational need Operational need Operational need |
- $ - - |
N/A N/A N/A |
- $ - - |
911,933 $ 774,814 406,071 |
3,647,733 $ 1,549,628 1,353,568 |
Note 1: If the amount of NTD in this Note relates to foreign currencies, it is converted to NTD at the exchange rate at the end of the financial reporting period.
Note 2: The ”Procedure for Provision of Loans” policy for loans granted by Altek Corporation is as follows: the ceiling on total loans is 40% of the net assets value of lender. For a single enterprise, the ceiling on loans is 10% of the net assets value of lender.
Note 3: The ”Procedure for Provision of Loans” policy for loans granted by Altek (Kunshan) Co., Ltd. is as follows: the ceiling on total loans is 40% of the net assets value of lender. For a single enterprise, the ceiling on loans is 20% of the net assets value of lender.
Note 4: The ”Procedure for Provision of Loans” policy for loans granted by Altek International Holding (BVI) Co., Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. For a single enterprise, the ceiling on loans is 30% of the net assets value of lender.
Table 1
Altek Corporation and subsidiaries
Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)
June 30, 2024
| June 30, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Table 2 Securitiesheld by |
Marketable securities | Relationship with the securitiesissuer |
General ledgeraccount |
As ofJune | 30,2024 Expressed in thousands of NTD (Except as otherwise indicated) |
||
| Numberofshares | Bookvalue | Ownership (%) | Fairvalue | ||||
| Altek Corporation Altek Medical Pte. Ltd. Altek Corporation Altek (Kunshan) Co., Ltd. Altek EMS (Kunshan) Co., Ltd. Altek International Investment Co., Ltd. " " |
Gianta Co., Ltd. - Common stock Profusa, Inc.-Convertible notes Hua-chuang Automobile Information Technical Center Co., Ltd. - Common stock CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership) Aimore Acoustics Incorporation Apple Inc.-Corporate bond Microsoft Corp-Corporate bond Procter & Gamble Company-Corporate bond |
Director None None None Director None None None |
Financial assets at fair value through profit or loss - non-current " Financial assets measured at fair value through other comprehensive income - non-current " " Financial assets at amortised cost - non-current " " |
762,876 - 2 N/A N/A N/A N/A N/A |
89,240 $ 36,163 - 38,361 - 95,271 94,893 93,349 |
14.55% N/A 0.00% 1% 12.5% N/A N/A N/A |
89,240 $ 36,163 - 38,361 - 95,271 94,893 93,349 |
Table 2
Table 3
Altek Corporation and subsidiaries
Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more
For the six-month period ended June 30, 2024
Expressed in thousands of NTD (Except as otherwise indicated)
| Purchaser/seller | Counterparty | Relationship with the counterparty |
Transaction | Transaction | Differences in transaction terms compared to third party transactions |
Differences in transaction terms compared to third party transactions |
Notes/accounts receivable(payable) |
Notes/accounts receivable(payable) |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Purchases (sales) |
Amount | Percentage of total purchases (sales) |
Credit term | Unitprice | Credit term | Balance | Percentage of total notes/accounts receivable(payable) |
|||
| Altek Corporation Altek International Trading Co., Ltd. Altek Biotechnology Corporation Altek Medical Pte. Ltd. " Altek (Kunshan) Co., Ltd. |
Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited Altek Medical (Kunshan) Limited Altek Biotechnology Corporation Altek International Trading Co., Ltd. |
Parent-subsidiary The same ultimate parent company The same parent company Parent-subsidiary Parent-subsidiary The same parent company |
Purchases Purchases Purchases Purchases Purchases Purchases |
857,346 $ 967,771 845,477 232,871 757,512 124,657 |
88% 100% 100% 23% 74% 9% |
Net 120 days Net 75 days " " " " |
Approximately the same price with third parties " " " " " |
Note " " " " " |
563,187) ($ 323,420) ( 371,003) ( 169,984) ( 513,265) ( - |
86% 100% 99% 24% 71% 0% |
Note: The payment term with third parties was net 60~120 days.
Table 3
Altek Corporation and subsidiaries
Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more
June 30, 2024
Table 4
Expressed in thousands of NTD (Except as otherwise indicated)
| Creditor | Counterparty | Relationship with the counterparty |
Balance as atJune30,2024 | Turnover rate | Overdue receivables | Overdue receivables | Amount collected subsequent to the balance sheet date |
Allowance for doubtful accounts |
Note |
|---|---|---|---|---|---|---|---|---|---|
| Amount | Action taken | ||||||||
| Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited " Altek Biotechnology Corporation |
Altek Corporation Altek International Trading Co., Ltd. Altek Biotechnology Corporation Altek Medical Pte. Ltd. " |
Parent-subsidiary The same ultimate parent company The same parent company Parent-subsidiary Parent-subsidiary |
563,187 $ 323,420 371,003 169,984 513,265 |
3.41 5.02 4.16 6.16 5.42 |
- $ - - - - |
N/A N/A N/A N/A N/A |
89,714 $ 81,156 246,714 51,277 296,986 |
- $ - - - - |
Note: It is a loan to related party, shown as other receivables.
Table 4
Altek Corporation and subsidiaries
Significant inter-company transactions during the reporting periods
For the six-month period ended June 30, 2024
Table 5
Expressed in thousands of NTD
(Except as otherwise indicated)
| Companyname | Counterparty | Relationship (Note1) |
Transaction | |||
|---|---|---|---|---|---|---|
| General ledgeraccount | Amount | Transactionterms | Percentage of consolidated total operating revenues ortotalassets (Note2) |
|||
| Altek Corporation " Altek International Trading Co., Ltd. " Altek Biotechnology Corporation " Altek Medical Pte. Ltd. " " " " " Altek Medical Sdn.Bhd. " Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited " |
Altek International Trading Co., Ltd. " Altek (Kunshan) Co., Ltd. " Altek Medical (Kunshan) Limited " Altek Medical (Kunshan) Limited " Altek Biotechnology Corporation " Altek Medical Sdn.Bhd. " Altek Medical (Kunshan) Limited " Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. " |
(1) (1) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) |
Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Purchases Accounts payable |
857,346 $ 563,187 967,771 323,420 845,477 371,003 232,871 169,984 757,512 513,265 39,110 38,612 50,223 49,983 124,657 36,065 94,672 |
Net 120 days " Net 75 days " " " " " " " " " " " " " " |
26% 4% 29% 2% 26% 2% 7% 1% 23% 3% 1% 0% 2% 0% 4% 1% 1% |
Note 1: Relationship between transaction and counterparty is classified into the following categories:
(1) Parent company to subsidiary.
(2) Subsidiary to parent company.
(3) Subsidiary to subsidiary.
Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.
Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.
Table 5
Altek Corporation and subsidiaries
Information on investees
Expressed in thousands of NTD (Except as otherwise indicated)
For the six-month period ended June 30, 2024
Table 6
| Investor | Investee | Location | Main business activities | Initial investment amount | Initial investment amount | Shares | held as at June 30, | 2024 | Net profit (loss) of the investee for the six-month period ended June 30,2024 |
Investment income(loss) recognised by the Company for the the six-month period ended June 30,2024 |
Footnote |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as at June 30, 2024 |
Balance as at December 31, 2023 |
Number of shares | Ownership (%) | Book value | |||||||
| Altek Corporation " " " " Altek International Investment Co., Ltd. " " " Altek Semiconductor (Cayman) Co., Ltd. Altek Medical Pte. Ltd. " " " |
Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co, Ltd. Altek Investment Corporation Altek Medical Pte. Ltd. Altek Lab Inc. Altek Semiconductor (Cayman) Co., Ltd. Altek Optical Technology (Cayman) Co., Ltd. Altek International Trading Co,. Ltd. Altek Semiconductor Corporation Altek Biotechnology Corporation Altek Medical (HongKong) Limited Altek Biotechnology Pte. Ltd. Altek Medical Sdn.Bhd. |
British Virgin Islands Japan British Virgin Islands Republic of China Singapore U.S.A. Cayman Islands Cayman Islands Republic of Seychelles Republic of China Republic of China HongKong Singapore Malaysia |
Investment Buying and selling of electronic components Investment Investment Research and development, sales of medical electronic equipment and investment Collection of American digital imaging technology information and design services Investment Investment Intercompany transactions Research design and sales of ASIC Research and development, manufacture and sales of medical electronic equipments Investment Research and development, and sales of medical electronic equipments Manufacture and sales of medical electronic equipments |
$ 2,882,512 2,869 415,376 100,000 755,272 119,407 433,117 429,833 324,500 500,000 25,376 48,675 16,225 129,800 |
2,882,512 $ 2,869 415,376 100,000 755,272 119,407 433,117 429,833 324,500 500,000 25,376 38,940 16,225 64,900 |
87,769,559 1,000 12,865,921 10,000,000 45,063,684 11,311,875 43,000,000 13,246,000 10,000,000 50,000,000 1,100,000 N/A 500,000 18,234,000 |
100 100 100 100 69.87 100 100 100 100 100 100 100 100 100 |
8,595,028 $ 9,396 1,382,668 100,361 848,408 69,937 123,442 144,506 237,056 118,328 963,457 102,912 13,068 111,488 |
96,977 $ 53 27,717 126 212,031 760 14,629 1,737 14,996) ( 14,576 105,598 9,136) ( 25 7,637) ( |
98,771 $ 53 27,717 126 156,260 760 15,993 1,737 14,996) ( 14,576 78,384 6,890) ( 17 5,053) ( |
Note 1 Note 1 Note 2 Note 1 Note 2 Note 2 Note 2 Note 2 Note 1 Note 2 |
Note 1: The difference between the profit or loss of the investee for the current period and the investment profit or loss recognized in the current period is the unrealized profit and loss adjustments for countercurrent transactions between subsidiaries. Note 2: The difference between the profit and loss of the investee company in the current period and the investment profit and loss recognized in the current period is based on the shareholding ratio.
Table 6
Altek Corporation and subsidiaries
Information on investments in Mainland China
Table 7
Expressed in thousands of NTD
For the six-month period ended June 30, 2024
(Except as otherwise indicated)
| Investee in Mainland China |
Main business activities | Paid-in capital | Investment method (Note 1) |
Accumulated amount of remittance from Taiwan to Mainland China as of January1,2024 |
Amount remitted from Taiwan to Mainland China/Amount remitted back to Taiwan for the six-month period ended June 30,2024 |
Amount remitted from Taiwan to Mainland China/Amount remitted back to Taiwan for the six-month period ended June 30,2024 |
Accumulated amount of remittance from Taiwan toMainland China as of June 30,2024 |
Net profit (loss) of investee for the six-month period ended June 30,2024 |
Ownership held by the Company (direct or indirect) |
Investment income (loss) recognised by the Company for the six-month period ended June 30, 2024 (Note 4) |
Accumulated amount of investment income remitted back to Taiwan as of June 30,2024 Book value of investments in Mainland China as of June 30,2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Remitted to MainlandChina |
Remitted back to Taiwan |
||||||||||
| Altek (Kunshan) Co., Ltd. (Note 2) Manufacture and sale of digital still cameras and its accessories 572,094 $ 2 1,460,250 $ - $ Altek EMS (Kunshan) Co., Ltd. (Note 3) Production /sales of electronic product components 162,250 2 294,743 - Altek Trading (Shanghai) Limited Wholesale, import and export of digital cameras, digital video cameras and their associated accessories 275,825 2 275,825 - Altek Precision (Kunshan) Co., Ltd. Design, manufacture and sales of digital camera parts 447,810 2 447,810 - Altek Optical Technology (Kunshan) Co., Ltd. Manufacture and sale of components for electronic related products 454,300 2 431,585 - Altek Semiconductor (Shanghai) Co., Ltd. Research design and sales of imaging technologies, electronic software and hardware 48,675 2 - - Altek Medical (Shanghai) Limited Sales of medical electronic equipment 32,450 2 - - Altek Medical (Kunshan) Limited Manufacture and sale of medical electronic equipment 27,319 2 - - Jia Jing Business Management (Kunshan) Co., Ltd. (Note 5) Business management and non-residential real estate leasing 613,954 2 - - Hong Jing Business Management (Kunshan) Co., Ltd. (Note 5) Business management, housing leasing and property management 423,473 2 - - Note 1: Investment methods are classified into the following three categories; fill in the number of category each case belongs to: (1)Directly invest in a company in Mainland China. (2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China. (3)Others. Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars). Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars). Note 4: The basic explanation of investment profit and loss recognition is audited by the R.O.C. parent company’s independent auditors. (1)Altek (Kunshan) Co., Ltd. are reviewed by the R.O.C. parent company’s independent auditors. (2)Other companies are self-consolidated financial statements. Note 5: It was established by Altek (Kunshan) Co., Ltd. Companyname Accumulated amount of remittance from Taiwan to Mainland China as of June 30,2024 |
- $ 1,460,250 $ 91,151 $ - 294,743 5,076 - 275,825 9,163) ( - 447,810 1,718 - 431,585 2,316 - - 2,815) ( - - 3,080) ( - - 11,811 - - 20,485 - - 6,794) ( Investment amount approved by the Investment Commission of the Ministryof Economic Affairs(MOEA) |
100 91,151 $ 3,874,100 $ - $ 100 5,076 580,202 97,350 100 9,163) ( 276,742 - 100 1,718 168,796 - 75 1,737 144,503 - 100 2,815) ( 106,729 - 69.87 2,407) ( 92,818 - 69.87 8,630 85,292 - 100 20,485 681,003 - 100 6,794) ( 448,430 - Ceiling on investments in Mainland China imposed bythe Investment Commission of MOEA |
|||||||||
| Altek Corporation | $2,910,213 | $3,192,225 | $5,471,599 |
Accumulated amount of remittance from Taiwan to Company name Mainland China as of June 30, 2024 Altek Corporation $2,910,213
Table 7
Altek Corporation and subsidiaries Information of major shareholders June 30, 2024
Table 8
| Name of major shareholders | Shares | Shares |
|---|---|---|
| Number of shares held | Holding percentage | |
| Yitsang International Co., Ltd. | 14,830,100 | 5.31% |
Table 8